@NP	Olfactory Ensheathing Cells Transplanted in Lesioned Spinal Cord	1
@NP	Olfactory Ensheathing Cells	1
@NP	Lesioned Spinal Cord	45
@NP	Loss of Spinal Cord Parenchyma	74
@NP	Loss	74
@NP	Spinal Cord Parenchyma	82
@NP	Functional Recovery ENRIQUE VERDU '	117
@NP	,1	153
@NP	GUILLERMO GARCI'A - ALI'AS ,1 JOAQUIM FORE '	157
@NP	GUILLERMO GARCI'A	157
@NP	ALI'AS	175
@NP	,1 JOAQUIM FORE	181
@NP	,1,2 RUBEN LO ' PEZ-VALES ,1	199
@NP	,1,2 RUBEN LO ' PEZ-VALES	199
@NP	,1,2	199
@NP	RUBEN LO ' PEZ-VALES	204
@NP	RUBEN LO '	204
@NP	,1	223
@NP	XAVIER NAVARRO1 ABSTRACT We studied the effects of olfactory ensheathing cells	230
@NP	XAVIER NAVARRO1 ABSTRACT	230
@NP	We	256
@NP	the effects of olfactory ensheathing cells	267
@NP	the effects	267
@NP	olfactory ensheathing cells	282
@NP	OECs	311
@NP	a photochemical spinal cord injury in adult rats	333
@NP	a photochemical spinal cord injury	333
@NP	adult rats	371
@NP	dorsal laminectomy at T8 vertebra	389
@NP	dorsal laminectomy	389
@NP	T8 vertebra	411
@NP	subjacent spinal cord	424
@NP	Bengal for 10 min	467
@NP	Bengal	467
@NP	10 min	478
@NP	visible light	506
@NP	means	523
@NP	an optic fiber	532
@NP	a halogen lamp for 2.5 min	560
@NP	a halogen lamp	560
@NP	2.5 min	579
@NP	maximal intensity of 8 kLux	590
@NP	maximal intensity	590
@NP	8 kLux	611
@NP	Eight injured rats	619
@NP	a suspension of OECs	647
@NP	a suspension	647
@NP	OECs	663
@NP	DMEM	671
@NP	another eight rats	681
@NP	DMEM	709
@NP	Locomotor ability	721
@NP	the BBB scale	749
@NP	pain sensibility by the plantar algesimetry test	764
@NP	pain sensibility	764
@NP	the plantar algesimetry test	784
@NP	motor - and somatosensory - evoked potentials by electrophysiological techniques	818
@NP	motor - and somatosensory -	818
@NP	motor	818
@NP	somatosensory	829
@NP	potentials	851
@NP	electrophysiological techniques	865
@NP	3 months postsurgery	916
@NP	all rats	947
@NP	paraformaldehyde	975
@NP	transverse sections from the spinal cord segment at the lesion site	996
@NP	transverse sections	996
@NP	the spinal cord segment at the lesion site	1021
@NP	the spinal cord segment	1021
@NP	the lesion site	1048
@NP	GFAP	1091
@NP	Area of the preserved spinal cord parenchyma	1097
@NP	Area	1097
@NP	the preserved spinal cord parenchyma	1105
@NP	the GFAPimmunolabeled cord sections	1160
@NP	The BBB score and the amplitude of motor - and somatosensory - evoked potentials	1197
@NP	The BBB score	1197
@NP	the amplitude of motor - and somatosensory - evoked potentials	1215
@NP	the amplitude	1215
@NP	motor - and somatosensory - evoked potentials	1232
@NP	motor	1232
@NP	somatosensory	1243
@NP	potentials	1265
@NP	OECs-transplanted rats	1291
@NP	DMEMinjected animals throughout follow-up	1322
@NP	DMEMinjected animals	1322
@NP	follow-up	1354
@NP	the withdrawal response to heat noxious stimulus	1373
@NP	the withdrawal response	1373
@NP	heat noxious stimulus	1400
@NP	lower in OEC	1426
@NP	lower	1426
@NP	OEC	1435
@NP	DMEM-injected rats	1448
@NP	The area of preserved spinal cord	1468
@NP	The area	1468
@NP	preserved spinal cord	1480
@NP	OECs-transplanted rats	1530
@NP	DMEM-injected animals	1561
@NP	These results	1584
@NP	OECs	1612
@NP	functional and morphological preservation of the spinal cord	1625
@NP	functional and morphological preservation	1625
@NP	the spinal cord	1670
@NP	photochemical injury	1692
@NP	INTRODUCTION	1715
@NP	lesion to the mammalian spinal cord , injured axons	1734
@NP	lesion	1734
@NP	the mammalian spinal cord , injured axons	1744
@NP	the mammalian spinal cord	1744
@NP	axons	1779
@NP	the lesion site	1811
@NP	synaptic connections	1850
@NP	their targets	1876
@NP	a consequence	1894
@NP	damage to the spinal cord	1909
@NP	damage	1909
@NP	the spinal cord	1919
@NP	permanent deficits	1946
@NP	partial or complete paralysis and sensory loss	1976
@NP	partial or complete paralysis	1976
@NP	sensory loss	2010
@NP	the level of lesion	2029
@NP	the level	2029
@NP	lesion	2042
@NP	the last years	2053
@NP	numerous studies	2069
@NP	the factors that limit spinal cord regeneration	2112
@NP	the factors	2112
@NP	spinal cord regeneration	2135
@NP	different strategies	2174
@NP	the repair of such injuries -LRB- Ramer et al. , 2000 -RRB-	2199
@NP	the repair	2199
@NP	such injuries -LRB- Ramer et al. , 2000 -RRB-	2213
@NP	such injuries	2213
@NP	Ramer	2228
@NP	et al. , 2000	2234
@NP	et al.	2234
@NP	2000	2242
@NP	Most experimental studies	2249
@NP	techniques	2285
@NP	us	2307
@NP	spinal cord injuries	2327
@NP	weight drop -LRB- Allen , 1911 ; Basso et al. , 1995 -RRB-	2357
@NP	weight drop	2357
@NP	Allen , 1911 ; Basso et al. , 1995	2370
@NP	Allen	2370
@NP	1911 ; Basso et al.	2377
@NP	1911	2377
@NP	Basso et al.	2383
@NP	Basso	2383
@NP	et al.	2389
@NP	1995	2397
@NP	aneurysm clip	2404
@NP	Fehlings and Tator , 1995 ; Joshi and Fehlings , 2002a , b	2419
@NP	Fehlings and Tator	2419
@NP	Fehlings	2419
@NP	Tator	2432
@NP	1995 ; Joshi and Fehlings	2439
@NP	1995	2439
@NP	Joshi and Fehlings	2445
@NP	2002a , b	2465
@NP	2002a	2465
@NP	b	2472
@NP	photochemical -LRB- Prado et al. , 1987 -RRB-	2480
@NP	photochemical	2480
@NP	Prado	2495
@NP	et al. , 1987	2501
@NP	et al.	2501
@NP	1987	2509
@NP	methods	2515
@NP	These experimental paradigms	2524
@NP	the effects	2581
@NP	cord injuries	2603
@NP	functional recovery and their relationship	2620
@NP	functional recovery	2620
@NP	their relationship	2644
@NP	histopathological results	2668
@NP	testing therapies that promote neural protection and axonal regeneration	2703
@NP	testing therapies	2703
@NP	neural protection and axonal regeneration	2734
@NP	neural protection	2734
@NP	axonal regeneration	2756
@NP	Pharmacological treatments	2777
@NP	Lankhorst	2805
@NP	et al. , 1999	2815
@NP	et al.	2815
@NP	1999	2823
@NP	Mu et al. , 2000	2829
@NP	Mu	2829
@NP	et al. , 2000	2832
@NP	et al.	2832
@NP	2000	2840
@NP	Yu et al. , 2000 -RRB-	2846
@NP	Yu	2846
@NP	et al.	2849
@NP	2000	2857
@NP	infusion	2864
@NP	diffusible growth factors	2876
@NP	McTigue et al. , 1998 ; Ankeny et al. , 2001 ; Kojima and Tator , 2002	2903
@NP	McTigue	2903
@NP	et al. , 1998 ; Ankeny et al. , 2001 ; Kojima and Tator , 2002	2911
@NP	et al. , 1998	2911
@NP	et al.	2911
@NP	1998	2919
@NP	Ankeny et al. , 2001	2925
@NP	Ankeny	2925
@NP	et al. , 2001	2932
@NP	et al.	2932
@NP	2001	2940
@NP	Kojima and Tator , 2002	2946
@NP	Kojima and Tator	2946
@NP	2002	2964
@NP	cellular transplants -LRB- Paino and Bunge , 1991	2975
@NP	cellular transplants -LRB- Paino and Bunge ,	2975
@NP	cellular transplants	2975
@NP	Paino and Bunge	2997
@NP	Paino	2997
@NP	Bunge	3007
@NP	1991	3014
@NP	Mc - Donald et al. , 1999	3020
@NP	Mc	3020
@NP	Donald et al. , 1999	3024
@NP	Donald	3024
@NP	et al. , 1999	3031
@NP	et al.	3031
@NP	1999	3039
@NP	spinal cord lesions	3074
@NP	Olfactory ensheathing cells -LRB- OECs -RRB-	3095
@NP	Olfactory ensheathing cells	3095
@NP	OECs	3124
@NP	remyelination	3137
@NP	spinal axons -LRB- Barnett et al. , 2000 ; Kato et al. , 2000 -RRB-	3167
@NP	spinal axons	3167
@NP	Barnett	3181
@NP	et al. , 2000 ; Kato et al. , 2000	3189
@NP	et al.	3189
@NP	2000 ; Kato et al.	3197
@NP	2000	3197
@NP	Kato et al.	3203
@NP	Kato	3203
@NP	et al.	3208
@NP	2000	3216
@NP	central nerve conduction -LRB- Imaizumi et al. , 1998 , 2000 -RRB-	3231
@NP	central nerve conduction	3231
@NP	Imaizumi	3257
@NP	et al. , 1998 , 2000	3266
@NP	et al.	3266
@NP	1998	3274
@NP	2000	3280
@NP	axonal regeneration	3299
@NP	Li	3320
@NP	et al. , 1998	3323
@NP	et al.	3323
@NP	1998	3331
@NP	Imaizumi et al. , 2000	3337
@NP	Imaizumi	3337
@NP	et al. , 2000	3346
@NP	et al.	3346
@NP	2000	3354
@NP	Ramo ' n-Cueto et al. , 2000	3360
@NP	Ramo ' n-Cueto et al.	3360
@NP	Ramo ' n-Cueto	3360
@NP	Ramo '	3360
@NP	et al.	3373
@NP	2000	3381
@NP	Lu et al.	3387
@NP	Lu	3387
@NP	et al.	3390
@NP	2001 , 2002	3398
@NP	2001	3398
@NP	2002	3404
@NP	transplantation	3416
@NP	lesioned spinal cords	3435
@NP	Significant recovery of motor and sensory functions	3458
@NP	Significant recovery	3458
@NP	motor and sensory functions	3482
@NP	OECs-transplanted rats	3526
@NP	DMEM-injected animals	3563
@NP	complete spinal cord transection	3591
@NP	Ramo ' n-Cueto et al. , 2000 ; Lu et al. , 2001 , 2002	3625
@NP	Ramo ' n-Cueto et al.	3625
@NP	Ramo ' n-Cueto	3625
@NP	Ramo '	3625
@NP	et al.	3638
@NP	2000 ; Lu et al.	3646
@NP	2000	3646
@NP	Lu et al.	3652
@NP	Lu	3652
@NP	et al.	3655
@NP	2001 , 2002	3663
@NP	2001	3663
@NP	2002	3669
@NP	These findings	3676
@NP	OECs	3716
@NP	axonal regeneration and functional recovery	3749
@NP	regeneration	3756
@NP	a severe spinal cord injury	3799
@NP	a previous study	3831
@NP	we	3849
@NP	severe photochemical cord injury	3873
@NP	OECs-transplanted rats	3907
@NP	significantly lower area of cystic cavity	3937
@NP	significantly lower area	3937
@NP	cystic cavity	3965
@NP	lower expression	3983
@NP	proteoglycan and glial fibrillary acidic protein -LRB- GFAP -RRB-	4003
@NP	proteoglycan	4003
@NP	glial fibrillary acidic protein -LRB- GFAP -RRB-	4020
@NP	glial fibrillary acidic protein	4020
@NP	GFAP	4053
@NP	reactive astrocytes in comparison	4062
@NP	reactive astrocytes	4062
@NP	comparison	4085
@NP	nontransplanted animals -LRB- Verdu ' et al. , 2001	4101
@NP	nontransplanted animals -LRB- Verdu ' et al.	4101
@NP	nontransplanted animals	4101
@NP	Verdu ' et al.	4126
@NP	Verdu '	4126
@NP	et al.	4133
@NP	2001	4141
@NP	In vitro studies	4148
@NP	OECs	4188
@NP	GFAP and proteoglycan expression	4202
@NP	reactive astrocytes -LRB- Lakatos et al. , 2000 , 2002 -RRB-	4238
@NP	reactive astrocytes	4238
@NP	Lakatos	4259
@NP	et al. , 2000 , 2002	4267
@NP	et al.	4267
@NP	2000	4275
@NP	2002	4281
@NP	These results	4288
@NP	OECs	4315
@NP	a favorable microenvironment	4327
@NP	the lesion site that permits the regeneration of central axons	4359
@NP	the lesion site	4359
@NP	the regeneration of central axons	4388
@NP	the regeneration	4388
@NP	central axons	4408
@NP	the present work	4426
@NP	we	4444
@NP	the effects of OECs transplants on functional and electrophysiological recovery	4456
@NP	the effects	4456
@NP	OECs transplants on functional and electrophysiological recovery	4471
@NP	OECs transplants	4471
@NP	functional and electrophysiological recovery	4491
@NP	moderate photochemical spinal cord injury	4542
@NP	the first 3 months postoperation	4591
@NP	Locomotor activity , evaluated using open-field walking	4625
@NP	Locomotor activity	4625
@NP	open-field walking	4661
@NP	sensitivity of the hindpaw	4697
@NP	sensitivity	4697
@NP	the hindpaw	4712
@NP	functional tests	4737
@NP	Motor - and somatosensory-evoked potentials	4755
@NP	Motor	4755
@NP	somatosensory-evoked potentials	4766
@NP	the integrity of spinal cord pathways	4823
@NP	the integrity	4823
@NP	spinal cord pathways	4840
@NP	The area of preserved cord parenchyma	4862
@NP	The area	4862
@NP	preserved cord parenchyma	4874
@NP	spinal cord sections immunostained against GFAP	4918
@NP	spinal cord sections	4918
@NP	GFAP	4961
@NP	MATERIALS	4968
@NP	METHODS Culture of OECs	4982
@NP	METHODS Culture	4982
@NP	OECs	5001
@NP	Immunopurification	5007
@NP	Cryopreservation Primary cultures	5031
@NP	OECs from adult -LRB- 2.5 - to 3.0 - month-old -RRB- female Sprague-Dawley rats	5068
@NP	OECs	5068
@NP	adult -LRB- 2.5 - to 3.0 - month-old -RRB- female Sprague-Dawley rats	5078
@NP	2.5	5085
@NP	3.0	5093
@NP	the method	5175
@NP	Gudin˜ o-Cabrera and Nieto-Sampedro -LRB- 1996 , 2000 -RRB-	5199
@NP	Gudin˜ o-Cabrera and Nieto-Sampedro	5199
@NP	1996	5236
@NP	2000	5242
@NP	minor modifications	5253
@NP	Olfactory bulbs	5274
@NP	Hank 's balanced salt solution -LRB- HBSS ; Sigma -RRB-	5329
@NP	Hank 's balanced salt solution	5329
@NP	Hank 's	5329
@NP	HBSS ; Sigma	5360
@NP	HBSS	5360
@NP	Sigma	5366
@NP	calcium and magnesium	5378
@NP	0 °C	5403
@NP	The meningeal layer	5408
@NP	fine forceps	5450
@NP	the bulbs	5468
@NP	0.25 % trypsin	5496
@NP	0.1 % collagenase A	5511
@NP	0.1 % Dnase-I -LRB- Boehringer Mannheim , Germany -RRB-	5535
@NP	0.1 % Dnase-I	5535
@NP	Boehringer Mannheim	5549
@NP	Germany	5570
@NP	1 ml HBSS at 37 °C for 45 -- 60 min	5582
@NP	1 ml HBSS	5582
@NP	37 °C for 45 -- 60 min	5595
@NP	37 °C for 45	5595
@NP	37 °C	5595
@NP	45	5604
@NP	60 min	5607
@NP	incubation	5621
@NP	tissue dissociation	5633
@NP	gentle trituration	5665
@NP	a flame-constricted Pasteur pipette	5690
@NP	enzymes	5732
@NP	the addition	5760
@NP	10 ml	5776
@NP	Dulbecco 's minimum essential medium nutrient mixture F-12 Ham	5785
@NP	Dulbecco 's	5785
@NP	DMEM ; Sigma	5848
@NP	DMEM	5848
@NP	Sigma	5854
@NP	10 % fetal calf serum	5866
@NP	FCS	5888
@NP	Biological Industries	5893
@NP	Israel	5916
@NP	The cell mixture	5925
@NP	centrifugation	5959
@NP	900 rpm for 7 min	5977
@NP	900 rpm	5977
@NP	7 min	5989
@NP	culture medium	6014
@NP	Cells	6030
@NP	25 cm2 flasks	6058
@NP	poly-L-lysine -LRB- 10 µg/ml ; Sigma -RRB-	6084
@NP	poly-L-lysine	6084
@NP	10 µg/ml ; Sigma	6099
@NP	10 µg/ml	6099
@NP	Sigma	6109
@NP	5 % CO2 at 37 °C	6134
@NP	5 % CO2	6134
@NP	37 °C	6144
@NP	Culture medium	6150
@NP	DMEM with 10 % FCS	6169
@NP	DMEM	6169
@NP	10 % FCS	6179
@NP	9 days in vitro	6191
@NP	9 days	6191
@NP	this medium	6208
@NP	a defined medium	6236
@NP	OECs -LRB- Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 -RRB-	6267
@NP	OECs	6267
@NP	Gudin˜ o-Cabrera and Nieto-Sampedro , 2000	6273
@NP	Gudin˜ o-Cabrera and Nieto-Sampedro	6273
@NP	2000	6310
@NP	confluency -LRB- about 15 days in culture -RRB-	6332
@NP	confluency	6332
@NP	15 days in culture	6350
@NP	15 days	6350
@NP	culture	6361
@NP	the cell monolayer	6371
@NP	HBSS	6412
@NP	calcium and magnesium	6425
@NP	4 °C	6451
@NP	incubation	6472
@NP	trypsin -LRB- 0.05 % w/v -RRB-	6488
@NP	trypsin	6488
@NP	0.05 % w/v	6497
@NP	0.05 %	6497
@NP	w/v	6503
@NP	EDTA -LRB- 0.02 % ; Sigma -RRB-	6508
@NP	EDTA	6508
@NP	0.02 % ; Sigma	6514
@NP	0.02 %	6514
@NP	Sigma	6521
@NP	Trypsin action	6529
@NP	the addition of medium	6560
@NP	the addition	6560
@NP	medium	6576
@NP	the cell mixture	6587
@NP	centrifugation	6621
@NP	900 rpm for 7 min	6639
@NP	900 rpm	6639
@NP	7 min	6651
@NP	OECs	6658
@NP	mean of magnetic Dynabeads	6686
@NP	mean	6686
@NP	magnetic Dynabeads	6694
@NP	M-450 -LRB- DBM - 450 , Dynal , Oslo -RRB-	6713
@NP	M-450	6713
@NP	DBM	6720
@NP	450 , Dynal , Oslo	6725
@NP	450	6725
@NP	Dynal , Oslo	6730
@NP	goat antimouse IgG	6758
@NP	mouse monoclonal 192 IgG antibodies	6795
@NP	192	6812
@NP	the p75-NGF receptor -LRB- Chemicon -RRB-	6846
@NP	the p75-NGF receptor	6846
@NP	Chemicon	6868
@NP	The cell mixture	6879
@NP	DMEM medium	6915
@NP	DBM-coated magnetic beads	6946
@NP	40 min	6977
@NP	The cells selectively attached to the magnetic beads	6998
@NP	The cells	6998
@NP	the magnetic beads	7032
@NP	the cells that did not express p75-NGF receptor with the help of a potent magnet	7071
@NP	the cells	7071
@NP	p75-NGF receptor	7102
@NP	the help of a potent magnet	7124
@NP	the help	7124
@NP	a potent magnet	7136
@NP	The magnet	7153
@NP	the complexes of magnetic beads-OECs	7173
@NP	the complexes	7173
@NP	magnetic beads-OECs	7190
@NP	the side of the polypropylene tube	7213
@NP	the side	7213
@NP	the polypropylene tube	7225
@NP	These complexes	7249
@NP	DMEM	7282
@NP	the unattached p75 negative cells	7300
@NP	the unattached p75	7300
@NP	negative cells	7319
@NP	The p75	7335
@NP	positive cells	7344
@NP	freezing medium -LRB- Sigma -RRB-	7379
@NP	freezing medium	7379
@NP	Sigma	7396
@NP	4 °C	7417
@NP	a -20 °C freezer for 10 min	7437
@NP	a -20 °C freezer	7437
@NP	10 min	7457
@NP	a deep freezer at -80 °C	7473
@NP	a deep freezer	7473
@NP	-80 °C	7491
@NP	transplantation	7502
@NP	frozen cell vials	7519
@NP	37 °C , washed two times by centrifugation -LRB- 900 rpm , 7 min -RRB- in DMEM	7552
@NP	37 °C	7552
@NP	two times	7565
@NP	centrifugation	7578
@NP	900 rpm , 7 min	7594
@NP	900 rpm	7594
@NP	7 min	7603
@NP	DMEM	7613
@NP	the pellet	7623
@NP	the same medium	7653
@NP	The cells	7670
@NP	2 h of thawing	7705
@NP	2 h	7705
@NP	thawing	7712
@NP	our conditions	7727
@NP	more than 90 % of cells in primary cultures	7743
@NP	more than 90 %	7743
@NP	cells in primary cultures	7760
@NP	cells	7760
@NP	primary cultures	7769
@NP	spindle-like morphology	7791
@NP	two or three processes	7820
@NP	less than 10 % of cells	7850
@NP	less than 10 %	7850
@NP	cells	7867
@NP	appearance	7885
@NP	A few macrophages/microglial cells	7897
@NP	our cultures	7956
@NP	accordance	7973
@NP	previous studies -LRB- Gudin˜ o-Cabrera and Nieto - Sampedro , 1996 -RRB-	7989
@NP	previous studies	7989
@NP	Gudin˜ o-Cabrera and Nieto - Sampedro , 1996	8007
@NP	Gudin˜	8007
@NP	o-Cabrera and Nieto - Sampedro , 1996	8014
@NP	o-Cabrera and Nieto	8014
@NP	o-Cabrera	8014
@NP	Nieto	8028
@NP	Sampedro , 1996	8035
@NP	Sampedro	8035
@NP	1996	8045
@NP	more than 97 % of the immunopurified cells	8052
@NP	more than 97 %	8052
@NP	the immunopurified cells	8069
@NP	the majority of transplanted OECs	8127
@NP	the majority	8127
@NP	transplanted OECs	8143
@NP	spindle-shaped p75-positive cells	8165
@NP	Schwann-cell-like phenotype	8213
@NP	Franceschini and Barnett	8242
@NP	1996	8268
@NP	Li et al. , 1998 ; Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 ; Wewetzer et al.	8274
@NP	Li	8274
@NP	et al. , 1998 ; Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 ; Wewetzer et al.	8277
@NP	et al. , 1998	8277
@NP	et al.	8277
@NP	1998	8285
@NP	Gudin˜ o-Cabrera and Nieto-Sampedro , 2000	8291
@NP	Gudin˜ o-Cabrera and Nieto-Sampedro	8291
@NP	2000	8328
@NP	Wewetzer et al.	8334
@NP	Wewetzer	8334
@NP	et al.	8343
@NP	2002	8351
@NP	Animal Surgery Sixteen adult female Sprague-Dawley rats -LRB- 250 -- 300 g -RRB-	8358
@NP	Animal Surgery Sixteen adult female Sprague-Dawley rats	8358
@NP	Animal Surgery	8358
@NP	Sixteen adult female Sprague-Dawley rats	8373
@NP	250 -- 300 g	8415
@NP	250	8415
@NP	300 g	8419
@NP	sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	8449
@NP	sodium pentobarbital	8449
@NP	50 mg/kg , i.p.	8471
@NP	50 mg/kg	8471
@NP	a heating pad	8507
@NP	body temperature constant	8533
@NP	The back of the animals	8560
@NP	The back	8560
@NP	the animals	8572
@NP	povidone iodine	8616
@NP	a longitudinal incision	8637
@NP	the skin and muscles extending from mid to low thoracic vertebrae	8664
@NP	the skin and muscles	8664
@NP	mid to low thoracic vertebrae	8700
@NP	mid	8700
@NP	low thoracic vertebrae	8707
@NP	The spinal cord	8740
@NP	a dorsal laminectomy	8771
@NP	T8 vertebra	8795
@NP	The dura	8808
@NP	penetration of solutions	8849
@NP	penetration	8849
@NP	solutions	8864
@NP	Rose Bengal -LRB- RB ; 1.5 % in saline ; Sigma -RRB-	8875
@NP	Rose Bengal	8875
@NP	RB ; 1.5 % in saline ; Sigma	8888
@NP	RB	8888
@NP	1.5 % in saline ; Sigma	8892
@NP	1.5 % in saline	8892
@NP	1.5 %	8892
@NP	saline	8900
@NP	Sigma	8908
@NP	the exposed spinal cord for 10 min	8939
@NP	the exposed spinal cord	8939
@NP	10 min	8967
@NP	The excess dye	8975
@NP	The excess	8975
@NP	a double saline rinse	9005
@NP	The lesion	9028
@NP	the exposed dorsal surface of the spinal cord by means of one optic fiber	9067
@NP	the exposed dorsal surface	9067
@NP	the spinal cord by means of one optic fiber	9097
@NP	the spinal cord	9097
@NP	means of one optic fiber	9116
@NP	means	9116
@NP	one optic fiber	9125
@NP	10 mm	9152
@NP	top of the cord	9161
@NP	top	9161
@NP	the cord	9168
@NP	The optic fiber	9178
@NP	a halogen lamp -LRB- Raypa , Barcelona , Spain -RRB-	9211
@NP	a halogen lamp	9211
@NP	Raypa	9227
@NP	Barcelona	9234
@NP	Spain	9245
@NP	The spinal cord	9253
@NP	maximal intensity of 8 kLux for 2.5 min	9288
@NP	maximal intensity	9288
@NP	8 kLux for 2.5 min	9309
@NP	8 kLux	9309
@NP	2.5 min	9320
@NP	damage	9340
@NP	the calorific source of the halogen lamp	9350
@NP	the calorific source	9350
@NP	the halogen lamp	9374
@NP	the illumination time	9399
@NP	the spinal cord	9421
@NP	saline solution	9453
@NP	Garcı ' a-Alı ' as et al. , 2002 ; Verdu ' et al. , 2002	9470
@NP	Garcı ' a-Alı ' as et al. , 2002 ; Verdu ' et al. ,	9470
@NP	Garcı ' a-Alı	9470
@NP	et al.	9485
@NP	2002 ; Verdu ' et al. ,	9493
@NP	2002	9493
@NP	Verdu ' et al.	9499
@NP	Verdu '	9499
@NP	et al.	9506
@NP	2002	9514
@NP	Thirty minutes	9521
@NP	injury	9542
@NP	eight animals	9550
@NP	four injections of a suspension of OECs -LRB- 45,000 in 3 µl DMEM -RRB-	9573
@NP	four injections	9573
@NP	a suspension of OECs -LRB- 45,000 in 3 µl DMEM -RRB-	9592
@NP	a suspension	9592
@NP	OECs -LRB- 45,000 in 3 µl DMEM -RRB-	9608
@NP	OECs	9608
@NP	45,000 in 3 µl DMEM	9614
@NP	45,000	9614
@NP	3 µl DMEM	9624
@NP	the exposed spinal cord -LRB- group OEC -RRB-	9640
@NP	the exposed spinal cord	9640
@NP	group OEC	9665
@NP	Each animal	9677
@NP	a total of 180,000 OECs	9698
@NP	a total	9698
@NP	180,000 OECs	9709
@NP	DMEM	9725
@NP	Another eight rats	9731
@NP	four injections of an equal volume of vehicle alone -LRB- group DMEM -RRB-	9759
@NP	four injections	9759
@NP	an equal volume of vehicle alone -LRB- group DMEM -RRB-	9778
@NP	an equal volume	9778
@NP	vehicle alone -LRB- group DMEM -RRB-	9797
@NP	vehicle alone	9797
@NP	group DMEM	9812
@NP	The suspension	9825
@NP	a glass micropipette	9860
@NP	means	9884
@NP	repeated 20-ms pulses	9893
@NP	10 psi -LRB- Picospitzer II , General Valve , Fairfield , NJ -RRB-	9918
@NP	10 psi	9918
@NP	Picospitzer II	9926
@NP	General Valve	9942
@NP	Fairfield , NJ	9957
@NP	Verdu ' et al. , 2001	9973
@NP	Verdu '	9973
@NP	al.	9983
@NP	2001	9988
@NP	the wound	10004
@NP	the animals	10029
@NP	a warm environment	10054
@NP	full recovery	10079
@NP	Amitriptyline -LRB- 150 µg/ml -RRB-	10094
@NP	Amitriptyline	10094
@NP	150 µg/ml	10109
@NP	the drinking water	10140
@NP	neuropathic pain -LRB- Navarro et al. , 1994 -RRB-	10170
@NP	neuropathic pain	10170
@NP	Navarro	10188
@NP	et al. , 1994	10196
@NP	et al.	10196
@NP	1994	10204
@NP	The experimental procedures	10211
@NP	the recommendations of the European Union and the U.S.	10250
@NP	the recommendations	10250
@NP	the European Union and the U.S.	10273
@NP	the European Union	10273
@NP	the U.S.	10296
@NP	Department of Health	10305
@NP	Department	10305
@NP	Health	10319
@NP	the care and use of laboratory animals	10330
@NP	the care and use	10330
@NP	laboratory animals	10350
@NP	the ethics committee of our institution	10390
@NP	the ethics committee	10390
@NP	our institution	10414
@NP	Functional Methods Functional tests	10431
@NP	Functional Methods	10431
@NP	Functional tests	10450
@NP	operation	10489
@NP	7 , 14 , 21 , 30 , 45 , 60 , and 90 days	10506
@NP	7	10506
@NP	14	10509
@NP	21	10513
@NP	30	10517
@NP	45	10521
@NP	60	10525
@NP	90 days	10533
@NP	postoperation	10541
@NP	Locomotor activity	10556
@NP	the open-field walking scoring system	10595
@NP	the locomotor ability for 5 min	10647
@NP	the locomotor ability	10647
@NP	5 min	10673
@NP	One animal at a time	10680
@NP	One animal	10680
@NP	a time	10694
@NP	a circular plastic tray -LRB- 90 cm diameter x 24 cm wall height -RRB-	10735
@NP	a circular plastic tray	10735
@NP	90 cm diameter x 24 cm wall height	10760
@NP	90 cm diameter	10760
@NP	24 cm wall height	10777
@NP	Two independent examiners	10797
@NP	the hindlimb movements of the rat	10832
@NP	the hindlimb movements	10832
@NP	the rat	10858
@NP	the locomotor function	10877
@NP	the BBB scale -LRB- Basso et al. , 1995 -RRB-	10913
@NP	the BBB scale	10913
@NP	Basso	10928
@NP	et al. , 1995	10934
@NP	et al.	10934
@NP	1995	10942
@NP	The final score of each animal	10949
@NP	The final score	10949
@NP	each animal	10968
@NP	the mean value of both examiners	10984
@NP	the mean value	10984
@NP	examiners	11007
@NP	The BBB scale	11018
@NP	0 -LRB- no hindlimb movement -RRB-	11044
@NP	0	11044
@NP	no hindlimb movement	11047
@NP	21 -LRB- normal movement-coordinated gait -RRB-	11072
@NP	21	11072
@NP	normal movement-coordinated gait	11076
@NP	Animals	11111
@NP	testing	11142
@NP	the inclined - plane method -LRB- Rivlin and Tator , 1977 -RRB-	11153
@NP	the inclined	11153
@NP	plane method -LRB- Rivlin and Tator , 1977 -RRB-	11167
@NP	plane method	11167
@NP	Rivlin and Tator , 1977	11181
@NP	Rivlin	11181
@NP	Tator , 1977	11192
@NP	Tator	11192
@NP	1977	11199
@NP	The maximum angle	11206
@NP	the animal	11233
@NP	a stable position	11259
@NP	5 s on the inclined plane	11281
@NP	5 s	11281
@NP	the inclined plane	11288
@NP	Nociceptive sensitivity	11321
@NP	a heat radiation method	11362
@NP	a plantar algesimeter -LRB- Hargreaves et al. , 1988 -RRB-	11392
@NP	a plantar algesimeter	11392
@NP	Hargreaves	11415
@NP	et al. , 1988	11426
@NP	et al.	11426
@NP	1988	11434
@NP	the rat	11450
@NP	a plastic box	11474
@NP	an elevated glass floor	11493
@NP	the bottom of the box	11523
@NP	the bottom	11523
@NP	the box	11537
@NP	the light of a projection lamp -LRB- 150 W -RRB-	11546
@NP	the light	11546
@NP	a projection lamp -LRB- 150 W -RRB-	11559
@NP	a projection lamp	11559
@NP	150 W	11578
@NP	the plantar surface of the hindpaw	11611
@NP	the plantar surface	11611
@NP	the hindpaw	11634
@NP	The time to withdrawal of the heated paw -LRB- withdrawal latency -RRB-	11647
@NP	The time	11647
@NP	withdrawal of the heated paw -LRB- withdrawal latency -RRB-	11659
@NP	withdrawal	11659
@NP	the heated paw -LRB- withdrawal latency -RRB-	11673
@NP	the heated paw	11673
@NP	withdrawal latency	11689
@NP	a time meter coupled with infrared detectors directed to the plantar surface	11730
@NP	a time meter	11730
@NP	infrared detectors directed to the plantar surface	11756
@NP	infrared detectors	11756
@NP	the plantar surface	11787
@NP	The maximal time of stimulation	11808
@NP	The maximal time	11808
@NP	stimulation	11828
@NP	40 s	11855
@NP	skin damage	11869
@NP	The value for a test	11882
@NP	The value	11882
@NP	a test	11896
@NP	the mean of three trials separated by 5-min resting periods	11907
@NP	the mean	11907
@NP	three trials separated by 5-min resting periods	11919
@NP	three trials	11919
@NP	5-min resting periods	11945
@NP	Electrophysiological Methods	11968
@NP	Motor - and somatosensory-evoked potentials	11997
@NP	Motor	11997
@NP	somatosensory-evoked potentials	12008
@NP	the integrity of spinal cord	12064
@NP	the integrity	12064
@NP	spinal cord	12081
@NP	tracts	12118
@NP	Animals	12126
@NP	sodium pentobarbital	12157
@NP	25 mg/kg , i.p.	12179
@NP	25 mg/kg	12179
@NP	a prone position	12209
@NP	a warmed flat coil	12231
@NP	a hot-water circulating pump to maintain skin temperature above 32 °C	12264
@NP	a hot-water	12264
@NP	pump	12288
@NP	skin temperature	12305
@NP	32 °C	12328
@NP	Motor-evoked potentials -LRB- MEPs -RRB-	12334
@NP	Motor-evoked potentials	12334
@NP	MEPs	12359
@NP	monopolar needle electrodes placed at the tibialis anterior muscle	12385
@NP	monopolar needle electrodes	12385
@NP	the tibialis anterior muscle	12423
@NP	the contralateral sensorimotor cortex	12459
@NP	single rectangular pulses of 0.1-ms duration	12515
@NP	single rectangular pulses	12515
@NP	0.1-ms duration	12544
@NP	needle electrodes	12579
@NP	the cathode over the skull overlying the sensorimotor cortex	12622
@NP	the cathode	12622
@NP	the skull overlying the sensorimotor cortex	12639
@NP	the skull	12639
@NP	the sensorimotor cortex	12659
@NP	the anode	12687
@NP	the nose	12700
@NP	This configuration	12710
@NP	transcranial stimulation	12738
@NP	subcortical efferent pathways	12778
@NP	Zappulla	12809
@NP	et al 1988 ; Adamson et al 1989	12818
@NP	et al 1988 ; Adamson et al	12818
@NP	et al 1988	12818
@NP	et al	12818
@NP	1988	12824
@NP	Adamson et al	12830
@NP	Adamson	12830
@NP	et al	12838
@NP	1989	12844
@NP	somatosensory-evoked potentials -LRB- SSEPs -RRB-	12855
@NP	somatosensory-evoked potentials	12855
@NP	SSEPs	12888
@NP	electrical stimuli 0.1 ms in duration and 4 mA in intensity	12896
@NP	electrical stimuli 0.1 ms in duration	12896
@NP	electrical stimuli	12896
@NP	0.1 ms in duration	12915
@NP	0.1 ms	12915
@NP	duration	12925
@NP	4 mA in intensity	12938
@NP	4 mA	12938
@NP	intensity	12946
@NP	5 Hz to the tibial nerve	12972
@NP	5 Hz	12972
@NP	the tibial nerve	12980
@NP	means of two needle electrodes inserted at the ankle	13000
@NP	means	13000
@NP	two needle electrodes inserted at the ankle	13009
@NP	two needle electrodes	13009
@NP	the ankle	13043
@NP	responses	13061
@NP	two needle electrodes	13091
@NP	the skull	13138
@NP	same sites as stimulation needles for MEPs	13149
@NP	same sites	13149
@NP	stimulation needles for MEPs	13163
@NP	stimulation needles	13163
@NP	MEPs	13187
@NP	A total of 256 responses	13194
@NP	A total	13194
@NP	256 responses	13205
@NP	100 ms following each stimulus	13240
@NP	100 ms	13240
@NP	each stimulus	13257
@NP	The signals	13285
@NP	bandpass 1 Hz/5 kHz for MEPs and 10 Hz/1 kHz for SSEPs	13323
@NP	bandpass 1 Hz/5 kHz for MEPs	13323
@NP	bandpass 1 Hz/5 kHz	13323
@NP	MEPs	13347
@NP	10 Hz/1 kHz for SSEPs	13356
@NP	10 Hz/1 kHz	13356
@NP	SSEPs	13372
@NP	the oscilloscope -LRB- Sapphire 4ME , Vickers -RRB- to measure the amplitude	13397
@NP	Sapphire 4ME	13415
@NP	Vickers	13429
@NP	the amplitude	13449
@NP	the latency of the evoked potentials -LRB- Nuwer , 1998 -RRB-	13467
@NP	the latency	13467
@NP	the evoked potentials -LRB- Nuwer , 1998 -RRB-	13482
@NP	the	13482
@NP	potentials -LRB- Nuwer , 1998 -RRB-	13493
@NP	potentials	13493
@NP	Nuwer	13505
@NP	1998	13512
@NP	reproducibility	13529
@NP	the recording and stimulating needles	13546
@NP	the recording	13546
@NP	stimulating needles	13564
@NP	a microscope	13602
@NP	the same placement	13625
@NP	all animals guided by anatomical landmarks	13647
@NP	all animals	13647
@NP	anatomical landmarks	13669
@NP	All electrophysiological tests	13691
@NP	operation	13744
@NP	14 , 30 , 60 , and 90 days	13761
@NP	14	13761
@NP	30	13765
@NP	60	13769
@NP	90 days	13777
@NP	postoperation	13785
@NP	Immunohistochemical Methods	13800
@NP	the end of functional and electrophysiological tests	13831
@NP	the end	13831
@NP	functional and electrophysiological tests	13842
@NP	the animals	13885
@NP	4 % paraformaldehyde	13948
@NP	phosphate - buffer saline solution -LRB- PBS , 0.1 M , pH 7.4 -RRB-	13971
@NP	phosphate	13971
@NP	buffer saline solution	13982
@NP	PBS	14006
@NP	0.1 M	14011
@NP	pH 7.4	14018
@NP	The spinal cords	14027
@NP	the same solution for 24 h	14067
@NP	the same solution	14067
@NP	24 h	14089
@NP	several segments	14110
@NP	All spinal cord segments	14128
@NP	PBS	14175
@NP	30 % sucrose	14190
@NP	4 °C	14216
@NP	Serial cryotome transverse sections	14221
@NP	40 µm	14257
@NP	the spinal cord segment subjacent	14274
@NP	T8 vertebra	14311
@NP	free floating	14335
@NP	PBS with 0.3 % Triton-X-100 -LRB- Fluka -RRB-	14352
@NP	PBS	14352
@NP	0.3 % Triton-X-100 -LRB- Fluka -RRB-	14361
@NP	0.3 % Triton-X-100	14361
@NP	Fluka	14380
@NP	1 % fetal calf serum -LRB- Biological Industries , Israel -RRB-	14391
@NP	1 %	14391
@NP	fetal calf serum -LRB- Biological Industries , Israel -RRB-	14394
@NP	fetal calf serum	14394
@NP	Biological Industries , Israel	14412
@NP	Biological Industries	14412
@NP	Israel	14435
@NP	1 h	14447
@NP	24 h at 4 °C with rabbit antisera	14469
@NP	24 h	14469
@NP	4 °C with rabbit antisera	14477
@NP	4 °C	14477
@NP	rabbit antisera	14486
@NP	GFAP -LRB- 1:1,000 , Chemicon -RRB-	14505
@NP	GFAP	14505
@NP	1:1,000	14511
@NP	Chemicon	14520
@NP	washes	14537
@NP	sections	14545
@NP	secondary antiserum	14574
@NP	donkey antirabbit	14595
@NP	Cy3-labeled immunoglobulin G -LRB- 1:200 , Jackson Immunoresearch -RRB-	14613
@NP	Cy3-labeled immunoglobulin G	14613
@NP	1:200	14643
@NP	Jackson Immunoresearch	14650
@NP	4 °C	14687
@NP	additional washes	14702
@NP	sections	14721
@NP	gelatin-coated slides	14746
@NP	ethanol	14783
@NP	DPX	14809
@NP	a specificity control	14817
@NP	some spinal cord sections	14840
@NP	primary antibody	14889
@NP	Samples	14940
@NP	an Olympus BX-51 microscope	14966
@NP	epifluorescence	15008
@NP	appropriate filters	15030
@NP	Low-power magnification -LRB- x4 -RRB- images of spinal cord sections	15051
@NP	Low-power magnification -LRB- x4 -RRB- images	15051
@NP	x4	15076
@NP	spinal cord sections	15090
@NP	the aid	15127
@NP	a digital camera	15138
@NP	Olympus DP50	15156
@NP	the microscope	15182
@NP	NIH Image software	15216
@NP	Spinal cord sections stained against GFAP	15236
@NP	Spinal cord sections	15236
@NP	GFAP	15273
@NP	the area of preserved cord parenchyma	15302
@NP	the area	15302
@NP	preserved cord parenchyma	15314
@NP	high-intensity staining	15349
@NP	reactive astrocytes	15389
@NP	the destroyed parenchyma	15436
@NP	Two independent subjects	15462
@NP	these measurements	15492
@NP	the same images	15516
@NP	the final area of preserved cord parenchyma of each transverse sections analyzed	15537
@NP	the final area	15537
@NP	preserved cord parenchyma of each transverse sections analyzed	15555
@NP	preserved cord parenchyma	15555
@NP	each transverse sections analyzed	15584
@NP	each transverse sections	15584
@NP	the mean value of both subjects	15622
@NP	the mean value	15622
@NP	subjects	15645
@NP	Between 8 and 10 transverse spinal cord sections per animal	15655
@NP	Between 8 and 10 transverse spinal cord sections	15655
@NP	animal	15708
@NP	Statistical Analysis	15729
@NP	All	15750
@NP	histological measurements	15792
@NP	a blinded manner	15836
@NP	A code of rats and histological slices	15854
@NP	A code	15854
@NP	rats and histological slices	15864
@NP	rats	15864
@NP	histological slices	15873
@NP	Data	15903
@NP	mean ± SEM	15921
@NP	Statistical comparisons between groups	15933
@NP	Statistical comparisons	15933
@NP	groups	15965
@NP	analysis of variance -LRB- ANOVA -RRB-	15985
@NP	analysis	15985
@NP	variance -LRB- ANOVA -RRB-	15997
@NP	variance	15997
@NP	ANOVA	16007
@NP	a posthoc Scheffe ' test for multiple comparisons	16019
@NP	a posthoc Scheffe ' test	16019
@NP	multiple comparisons	16047
@NP	specific differences between preand postoperative times	16080
@NP	specific differences	16080
@NP	preand postoperative times	16109
@NP	a paired t-test	16137
@NP	Differences	16163
@NP	P	16206
@NP	RESULTS	16217
@NP	1	16230
@NP	Evolution of -LRB- A -RRB- the locomotor activity	16233
@NP	Evolution	16233
@NP	A	16247
@NP	the locomotor activity	16250
@NP	the BBB	16286
@NP	score	16294
@NP	B	16302
@NP	the maximum angle in the inclined plane test	16305
@NP	the maximum angle	16305
@NP	the inclined plane test	16326
@NP	the time	16359
@NP	withdrawal	16371
@NP	the heated paw in the plantar algesimetry test over time in the DMEM	16385
@NP	the heated paw	16385
@NP	the plantar algesimetry test over time in the DMEM	16403
@NP	the plantar algesimetry test	16403
@NP	time in the DMEM	16437
@NP	time	16437
@NP	the DMEM	16445
@NP	circle	16462
@NP	OECs	16474
@NP	circle	16487
@NP	experimental groups	16495
@NP	P < 0.05 -LRB- asterisk -RRB- vs.	16516
@NP	P <	16516
@NP	P	16516
@NP	<	16518
@NP	0.05 -LRB- asterisk -RRB- vs.	16520
@NP	0.05 -LRB- asterisk -RRB-	16520
@NP	vs.	16536
@NP	DMEM group .	16540
@NP	DMEM	16540
@NP	group	16545
@NP	Fig. 2 .	16553
@NP	Fig.	16553
@NP	2	16558
@NP	electrophysiological recordings of -LRB- A -RRB- MEPs and -LRB- B -RRB- SSEPs	16568
@NP	electrophysiological recordings of -LRB- A -RRB- MEPs	16568
@NP	electrophysiological recordings	16568
@NP	-LRB- A -RRB- MEPs	16603
@NP	A	16604
@NP	B	16617
@NP	SSEPs	16620
@NP	rats of groups DMEM -LRB- left -RRB- and OECs -LRB- right -RRB-	16629
@NP	rats	16629
@NP	groups DMEM -LRB- left -RRB- and OECs -LRB- right -RRB-	16637
@NP	groups DMEM	16637
@NP	left	16650
@NP	OECs	16660
@NP	right	16666
@NP	0 , 30 ,	16676
@NP	0	16676
@NP	30	16679
@NP	90 days	16687
@NP	N1 , first negative wave complex	16707
@NP	N1	16707
@NP	first negative wave complex	16711
@NP	N2 , second negative wave complex	16740
@NP	N2	16740
@NP	second negative wave complex	16744
@NP	N3 , third negative wave complex	16774
@NP	N3	16774
@NP	third negative wave complex	16778
@NP	Horizontal scale , 5 ms ; vertical scale , 4 mV for all MEP recordings .	16807
@NP	Horizontal scale , 5 ms	16807
@NP	Horizontal scale	16807
@NP	5 ms	16825
@NP	vertical scale , 4 mV for all MEP recordings	16831
@NP	vertical scale	16831
@NP	4 mV for all MEP recordings	16847
@NP	4 mV	16847
@NP	all MEP recordings	16856
@NP	Horizontal scale , 10 ms ; vertical scale , 3 µV for all SSEP recordings .	16876
@NP	Horizontal scale , 10 ms	16876
@NP	Horizontal scale	16876
@NP	10 ms	16894
@NP	vertical scale , 3 µV for all SSEP recordings	16901
@NP	vertical scale	16901
@NP	3 µV for all SSEP recordings	16917
@NP	3 µV	16917
@NP	all SSEP recordings	16926
@NP	Fig. 3 .	16948
@NP	Fig.	16948
@NP	3	16953
@NP	Histogram representation	16956
@NP	the amplitude -LRB- top -RRB- and latency -LRB- bottom -RRB-	16984
@NP	the amplitude	16984
@NP	top	16999
@NP	latency	17008
@NP	bottom	17017
@NP	time of the MEPs	17030
@NP	time	17030
@NP	the MEPs	17038
@NP	the tibialis	17059
@NP	anterior muscle in the DMEM -LRB- opened bar -RRB- and OECs	17072
@NP	anterior muscle in the DMEM -LRB- opened bar -RRB-	17072
@NP	anterior muscle in the DMEM	17072
@NP	anterior muscle	17072
@NP	the DMEM	17091
@NP	bar	17108
@NP	OECs	17117
@NP	bar	17130
@NP	groups	17135
@NP	P < 0.05 -LRB- asterisk -RRB- vs.	17143
@NP	P <	17143
@NP	P	17143
@NP	<	17145
@NP	0.05 -LRB- asterisk -RRB- vs.	17147
@NP	0.05 -LRB- asterisk -RRB-	17147
@NP	vs.	17163
@NP	DMEM group	17167
@NP	DMEM	17167
@NP	group	17172
@NP	section symbol	17180
@NP	preoperative values from the same experimental group	17200
@NP	preoperative values	17200
@NP	the same experimental group	17225
@NP	Fig. 4 .	17255
@NP	Fig.	17255
@NP	4	17260
@NP	Histogram	17263
@NP	the amplitudes	17291
@NP	the N1 -LRB- top -RRB- , N2 -LRB- middle -RRB- , and N3 -LRB- bottom -RRB-	17309
@NP	the N1 -LRB- top -RRB-	17309
@NP	the N1	17309
@NP	top	17317
@NP	N2 -LRB- middle -RRB-	17323
@NP	N2	17323
@NP	middle	17327
@NP	N3 -LRB- bottom -RRB-	17340
@NP	N3	17340
@NP	bottom	17344
@NP	waves	17352
@NP	SSEPs over time in DMEM -LRB- opened bar -RRB- and OECs	17361
@NP	SSEPs over time in DMEM	17361
@NP	SSEPs	17361
@NP	time in DMEM	17372
@NP	time	17372
@NP	DMEM	17380
@NP	bar	17393
@NP	OECs	17402
@NP	bar	17415
@NP	groups	17420
@NP	P < 0.05 -LRB- asterisk -RRB- vs.	17428
@NP	P <	17428
@NP	P	17428
@NP	<	17430
@NP	0.05 -LRB- asterisk -RRB- vs.	17432
@NP	0.05 -LRB- asterisk -RRB-	17432
@NP	vs.	17448
@NP	DMEM group	17452
@NP	DMEM	17452
@NP	group	17457
@NP	section symbol	17465
@NP	preoperative values from the same experimental group	17485
@NP	preoperative values	17485
@NP	the same experimental group	17510
@NP	Fig. 5 .	17540
@NP	Fig.	17540
@NP	5	17545
@NP	Spinal cord sections	17548
@NP	GFAP	17591
@NP	the lesion site segment	17605
@NP	the DMEM -LRB- A -RRB- and OECs -LRB- B -RRB- groups	17634
@NP	the DMEM -LRB- A -RRB-	17634
@NP	the DMEM	17634
@NP	A	17644
@NP	OECs -LRB- B -RRB- groups	17651
@NP	OECs	17651
@NP	B	17657
@NP	groups	17660
@NP	Confocal images of astrocytes	17668
@NP	Confocal images	17668
@NP	astrocytes	17687
@NP	GFAP	17720
@NP	the gray matter of DMEM -LRB- C -RRB- and OECs -LRB- D -RRB- experimental groups	17728
@NP	the gray matter of DMEM -LRB- C -RRB-	17728
@NP	the gray matter	17728
@NP	DMEM -LRB- C -RRB-	17747
@NP	DMEM	17747
@NP	C	17753
@NP	OECs -LRB- D -RRB- experimental groups	17760
@NP	OECs	17760
@NP	D	17766
@NP	experimental groups	17769
@NP	Bar : A and B , 1,000 µm ; C and D , 25 µm .	17790
@NP	Bar	17790
@NP	A and B , 1,000 µm	17795
@NP	A and B	17795
@NP	1,000 µm	17804
@NP	C and D , 25 µm	17814
@NP	C and D	17814
@NP	25 µm	17823
@NP	the first week postoperation	17838
@NP	rats transplanted with OECs	17868
@NP	rats	17868
@NP	OECs	17891
@NP	their body weight	17907
@NP	rats injected with DMEM	17932
@NP	rats	17932
@NP	DMEM	17951
@NP	a decrease of their body weight	17969
@NP	a decrease	17969
@NP	their body weight	17983
@NP	14 to 90 days postoperation	18007
@NP	all animals of both experimental groups	18036
@NP	all animals	18036
@NP	both experimental groups	18051
@NP	weight	18090
@NP	Functional Results	18098
@NP	the spinal cord lesions	18124
@NP	all animals	18149
@NP	normal locomotor behavior -LRB- scored 21 -RRB-	18168
@NP	normal locomotor behavior	18168
@NP	21	18202
@NP	7 days postoperation	18210
@NP	both experimental groups	18235
@NP	the BBB score	18260
@NP	respect	18289
@NP	preoperative values	18300
@NP	the mean score value	18321
@NP	about 11 and 16 in the DMEM and the OEC group -LRB- P 0.05 -RRB-	18346
@NP	about 11 and 16	18346
@NP	the DMEM and the OEC group -LRB- P 0.05 -RRB-	18365
@NP	the DMEM	18365
@NP	the OEC group -LRB- P 0.05 -RRB-	18378
@NP	the OEC group	18378
@NP	P 0.05	18393
@NP	the following weeks	18425
@NP	the BBB score	18446
@NP	values	18491
@NP	18 and 19	18504
@NP	DMEM and OEC rats	18517
@NP	90 days postoperation -LRB- Fig. 1A -RRB-	18553
@NP	90 days postoperation	18553
@NP	Fig. 1A	18576
@NP	spite	18589
@NP	the fact	18598
@NP	the BBB score values	18612
@NP	OEC rats	18657
@NP	respect	18671
@NP	DMEM animals	18682
@NP	no significant differences	18696
@NP	the two groups	18741
@NP	14 to 90 days postoperation	18761
@NP	The preoperative mean values of the maximum angle in the inclined plane	18790
@NP	The preoperative mean values	18790
@NP	the maximum angle in the inclined plane	18822
@NP	the maximum angle	18822
@NP	the inclined plane	18843
@NP	47 °	18873
@NP	7 days postoperation	18881
@NP	the mean maximum angle	18903
@NP	36 °	18939
@NP	39 ° in DMEM and OECs rats , then	18947
@NP	39 °	18947
@NP	DMEM and OECs rats , then	18954
@NP	DMEM and OECs rats	18954
@NP	mean values of 43 ° and 45 ° in DMEM and OEC groups	19012
@NP	mean values of 43 °	19012
@NP	mean values	19012
@NP	43 °	19027
@NP	45 ° in DMEM and OEC groups	19035
@NP	45 °	19035
@NP	DMEM and OEC groups	19042
@NP	90 days postoperation	19065
@NP	all postoperative days	19095
@NP	the mean maximum angle	19119
@NP	OEC	19187
@NP	DMEM animals -LRB- Fig. 1B -RRB-	19199
@NP	DMEM animals	19199
@NP	Fig. 1B	19213
@NP	Nociceptive withdrawal responses evaluated by plantar algesimetry	19223
@NP	Nociceptive withdrawal responses	19223
@NP	plantar algesimetry	19269
@NP	a latency of about 15 s in both experimental groups	19293
@NP	a latency	19293
@NP	about 15 s in both experimental groups	19306
@NP	about 15 s	19306
@NP	both experimental groups	19320
@NP	lesion	19352
@NP	7 days postoperation	19363
@NP	the time of withdrawal of the heated paw	19385
@NP	the time	19385
@NP	withdrawal of the heated paw	19397
@NP	withdrawal	19397
@NP	the heated paw	19411
@NP	group DMEM with respect	19439
@NP	group DMEM	19439
@NP	respect	19455
@NP	preoperative values	19466
@NP	it	19495
@NP	preoperative values in OEC rats	19513
@NP	preoperative values	19513
@NP	OEC rats	19536
@NP	the next 3 weeks	19553
@NP	the withdrawal latency	19571
@NP	values about 24 and 19 s	19607
@NP	values	19607
@NP	24 and 19 s	19620
@NP	groups DMEM and OEC	19635
@NP	Significant differences	19656
@NP	groups OEC and DMEM for all postoperative days tested -LRB- Fig. 1C -RRB-	19698
@NP	groups OEC and DMEM	19698
@NP	all postoperative days tested	19722
@NP	all postoperative days	19722
@NP	Fig. 1C	19753
@NP	Electrophysiological Results The MEPs recorded prior to operation	19763
@NP	Electrophysiological Results	19763
@NP	The MEPs	19792
@NP	operation	19819
@NP	a single wave	19836
@NP	a mean latency of about 6 ms	19855
@NP	a mean latency	19855
@NP	6 ms	19879
@NP	amplitude of about 15 mV	19893
@NP	amplitude	19893
@NP	about 15 mV	19906
@NP	both groups -LRB- Fig. 2A -RRB-	19921
@NP	both groups	19921
@NP	Fig. 2A	19934
@NP	photochemical injury	19950
@NP	no changes in the latency	19972
@NP	no changes	19972
@NP	the latency	19986
@NP	the 90 days postoperation , while the amplitude decreased markedly in group DMEM	20019
@NP	the 90 days postoperation	20019
@NP	the amplitude	20052
@NP	group DMEM	20088
@NP	14 days postoperation	20103
@NP	MEPs	20126
@NP	five of eight DMEM rats	20148
@NP	five	20148
@NP	eight DMEM rats	20156
@NP	a mean amplitude of about 1 mV	20181
@NP	a mean amplitude	20181
@NP	1 mV	20207
@NP	all OEC rats	20220
@NP	a mean value amplitude of about 12 mV	20238
@NP	a mean value amplitude	20238
@NP	12 mV	20270
@NP	90 days postoperation	20280
@NP	MEPs	20303
@NP	three of eight DMEM rats	20330
@NP	three	20330
@NP	eight DMEM rats	20339
@NP	a mean amplitude value of about 0.03 mV	20360
@NP	a mean amplitude value	20360
@NP	0.03 mV	20392
@NP	all rats from the OEC experimental group	20407
@NP	all rats	20407
@NP	the OEC experimental group	20421
@NP	MEP responses	20455
@NP	a mean amplitude of about 15 mV	20474
@NP	a mean amplitude	20474
@NP	about 15 mV	20494
@NP	Significant differences	20507
@NP	DMEM and OEC groups	20550
@NP	all the postoperative days studied -LRB- Fig. 3 -RRB-	20573
@NP	all the postoperative days	20573
@NP	Fig. 3	20609
@NP	Control SSEPs	20618
@NP	a series of well-defined negative peaks	20639
@NP	a series	20639
@NP	well-defined negative peaks	20651
@NP	latencies of 14	20682
@NP	latencies	20682
@NP	14	20695
@NP	21	20699
@NP	30 ms	20707
@NP	N1 , N2 , and N3 waves , with mean amplitudes of about 13 ,	20720
@NP	N1	20720
@NP	N2 , and N3 waves , with mean amplitudes of about 13	20724
@NP	N2 , and N3 waves ,	20724
@NP	N2	20724
@NP	N3 waves	20732
@NP	mean amplitudes of about 13	20747
@NP	mean amplitudes	20747
@NP	about 13	20766
@NP	16 , and 12 µV , respectively	20776
@NP	16	20776
@NP	12 µV	20784
@NP	Fig. 2B	20805
@NP	14 days postoperation	20818
@NP	the amplitude of all three waves of the SSEPs	20841
@NP	the amplitude	20841
@NP	all three waves of the SSEPs	20858
@NP	all three waves	20858
@NP	the SSEPs	20877
@NP	respect	20916
@NP	preoperative values in both experimental groups	20927
@NP	preoperative values	20927
@NP	both experimental groups	20950
@NP	the amplitude of SSEPs	20985
@NP	the amplitude	20985
@NP	SSEPs	21002
@NP	group OEC	21036
@NP	group DMEM	21054
@NP	14 to 90 days postoperation -LRB- Fig. 4 -RRB-	21070
@NP	14 to 90 days postoperation	21070
@NP	Fig. 4	21099
@NP	injury	21114
@NP	no changes in the latency of the SSEPs	21122
@NP	no changes	21122
@NP	the latency of the SSEPs	21136
@NP	the latency	21136
@NP	the SSEPs	21151
@NP	Immunohistochemical Results	21176
@NP	group DMEM	21207
@NP	transverse GFAP-immunostained spinal cord sections from T8 spinal cord segment	21219
@NP	transverse GFAP-immunostained spinal cord sections	21219
@NP	T8 spinal cord segment	21275
@NP	an open cavity	21305
@NP	the dorsal , dorsolateral , and ventrolateral funiculi	21330
@NP	the dorsal	21330
@NP	dorsolateral	21342
@NP	ventrolateral funiculi	21360
@NP	canal central	21389
@NP	ventral funiculi , including gray matter of the ventral horns ,	21410
@NP	ventral funiculi	21410
@NP	gray matter of the ventral horns	21438
@NP	gray matter	21438
@NP	the ventral horns	21453
@NP	spinal cord parenchyma remains	21499
@NP	spinal cord parenchyma	21499
@NP	dorsal areas -LRB- Fig. 5A -RRB-	21543
@NP	dorsal areas	21543
@NP	Fig. 5A	21557
@NP	animals of group OEC	21570
@NP	animals	21570
@NP	group OEC	21581
@NP	desestructuration of the dorsal cord parenchyma	21592
@NP	desestructuration	21592
@NP	the dorsal cord parenchyma	21613
@NP	microcavities	21655
@NP	the white and gray matter	21679
@NP	enlargement of the central canal -LRB- Fig. 5B -RRB-	21709
@NP	enlargement	21709
@NP	the central canal -LRB- Fig. 5B -RRB-	21724
@NP	the central canal	21724
@NP	Fig. 5B	21743
@NP	The	21753
@NP	area of preserved spinal cord	21766
@NP	area	21766
@NP	preserved spinal cord	21774
@NP	4.15 ± 0.12 and 4.85 ± 0.12 mm2 in DMEM and OEC groups	21800
@NP	4.15 ± 0.12	21800
@NP	4.15 ±	21800
@NP	0.12	21807
@NP	4.85 ± 0.12 mm2 in DMEM and OEC groups	21816
@NP	4.85 ± 0.12 mm2	21816
@NP	0.12	21823
@NP	DMEM and OEC groups	21835
@NP	P < 0.001	21870
@NP	P	21870
@NP	< 0.001	21872
@NP	<	21872
@NP	0.001	21874
@NP	all rats	21885
@NP	hypertrophied astrocytes , heavily stained for GFAP ,	21895
@NP	hypertrophied astrocytes	21895
@NP	GFAP	21941
@NP	the cavity or the desestructured cord parenchyma	21964
@NP	the cavity	21964
@NP	the desestructured cord parenchyma	21978
@NP	The spinal cord parenchyma from DMEM rats	22014
@NP	The spinal cord parenchyma	22014
@NP	DMEM rats	22046
@NP	higher number of reactive hypertrophied astrocytes	22063
@NP	higher number	22063
@NP	reactive hypertrophied astrocytes	22080
@NP	long and robust processes	22120
@NP	all directions	22159
@NP	GFAP -LRB- Fig. 5C -RRB-	22198
@NP	GFAP	22198
@NP	Fig. 5C	22204
@NP	OECs-transplanted rats	22217
@NP	few astrocytes	22241
@NP	a hypertrophied appearance	22263
@NP	most	22295
@NP	slightly GFAP-stained cell bodies	22307
@NP	thin processes -LRB- Fig. 5D -RRB-	22346
@NP	thin processes	22346
@NP	Fig. 5D	22362
@NP	DISCUSSION The results of this study	22373
@NP	DISCUSSION The results	22373
@NP	DISCUSSION	22373
@NP	The results	22384
@NP	this study	22399
@NP	transplantation	22420
@NP	OECs in the site of a moderate photochemical injury to the rat spinal cord	22439
@NP	OECs	22439
@NP	the site of a moderate photochemical injury to the rat spinal cord	22447
@NP	the site	22447
@NP	a moderate photochemical injury to the rat spinal cord	22459
@NP	a moderate photochemical injury	22459
@NP	the rat spinal cord	22494
@NP	the loss of cord parenchyma	22538
@NP	the loss	22538
@NP	cord parenchyma	22550
@NP	the functional outcome	22579
@NP	3 months postinjury	22609
@NP	comparison with rats that received an injection of medium	22633
@NP	comparison	22633
@NP	rats that received an injection of medium	22649
@NP	rats	22649
@NP	an injection of medium	22668
@NP	an injection	22668
@NP	medium	22684
@NP	OECs-transplanted rats	22692
@NP	better locomotor function	22722
@NP	normal nociceptive responses	22762
@NP	Electrophysiological results	22792
@NP	the amplitude of the motor - and somatosensory-evoked potentials	22835
@NP	the amplitude	22835
@NP	the motor - and somatosensory-evoked potentials	22852
@NP	the motor	22852
@NP	somatosensory-evoked potentials	22867
@NP	OECs	22927
@NP	DMEM-injected rats	22941
@NP	evidence of functional preservation of descending and ascending spinal pathways	22971
@NP	evidence	22971
@NP	functional preservation of descending and ascending spinal pathways	22983
@NP	functional preservation	22983
@NP	spinal pathways	23035
@NP	the majority of human spinal cord injuries	23055
@NP	the majority	23055
@NP	human spinal cord injuries	23071
@NP	the mechanism of the primary injury	23099
@NP	the mechanism	23099
@NP	the primary injury	23116
@NP	acute compression or laceration	23138
@NP	the spinal cord	23173
@NP	displacement of bone or disk	23196
@NP	displacement	23196
@NP	bone or disk	23212
@NP	the spinal cord during fracture-dislo	23230
@NP	the spinal cord	23230
@NP	fracture-dislo	23253
@NP	cation or burst fracture of the spine -LRB- Tator , 1983 -RRB-	23269
@NP	cation or burst fracture	23269
@NP	the spine -LRB- Tator , 1983 -RRB-	23297
@NP	the spine	23297
@NP	Tator	23308
@NP	1983	23315
@NP	patients with acute spinal cord injury	23325
@NP	patients	23325
@NP	acute spinal cord injury	23339
@NP	the mechanical injury	23365
@NP	the cord	23404
@NP	there	23435
@NP	loss of neural functions	23453
@NP	loss	23453
@NP	neural functions	23461
@NP	the level of injury -LRB- Kakulas , 1984 ; Geisler et al. , 1991 -RRB-	23488
@NP	the level	23488
@NP	injury -LRB- Kakulas , 1984 ; Geisler et al. , 1991 -RRB-	23501
@NP	injury	23501
@NP	Kakulas , 1984 ; Geisler et al. , 1991	23509
@NP	Kakulas	23509
@NP	1984 ; Geisler et al.	23518
@NP	1984	23518
@NP	Geisler et al.	23524
@NP	Geisler	23524
@NP	et al.	23532
@NP	1991	23540
@NP	this reason	23551
@NP	several experimental models	23564
@NP	spinal cord lesions	23633
@NP	regeneration	23666
@NP	spinal cords	23701
@NP	Experimental models	23715
@NP	the compression type of acute cord trauma	23757
@NP	the compression type	23757
@NP	acute cord trauma	23781
@NP	the weight-dropping technique	23807
@NP	Allen , 1911 ; Basso et al. , 1995 , 1996	23838
@NP	Allen	23838
@NP	1911 ; Basso et al. , 1995	23845
@NP	1911	23845
@NP	Basso et al. , 1995	23851
@NP	Basso	23851
@NP	et al. , 1995	23857
@NP	et al.	23857
@NP	1995	23865
@NP	1996	23871
@NP	extradural inflatable balloon compression -LRB- Tarlov et al. , 1953 -RRB-	23878
@NP	extradural inflatable balloon compression	23878
@NP	Tarlov	23921
@NP	et al. , 1953	23928
@NP	et al.	23928
@NP	1953	23936
@NP	aneurysm clip compression	23947
@NP	Rivlin and Tator	23974
@NP	Rivlin	23974
@NP	Tator	23985
@NP	1978 ; Fehlings and Tator , 1995	23992
@NP	1978	23992
@NP	Fehlings and Tator , 1995	23998
@NP	Fehlings and Tator	23998
@NP	1995	24018
@NP	contusion or compression trauma to the spinal cord	24031
@NP	contusion or compression trauma	24031
@NP	the spinal cord	24066
@NP	sequential pathological changes	24083
@NP	hemorrhage , edema	24125
@NP	hemorrhage	24125
@NP	edema	24137
@NP	axonal and neuronal necrosis	24144
@NP	demyelination followed by cystic formation	24178
@NP	demyelination	24178
@NP	cystic formation	24204
@NP	the lesion site	24238
@NP	Schwab and Bartholdi , 1996 ; Taoka and Okajima , 1998 ; McGraw et al. , 2001	24255
@NP	Schwab and Bartholdi	24255
@NP	1996 ; Taoka and Okajima , 1998 ; McGraw et al.	24277
@NP	1996	24277
@NP	Taoka and Okajima , 1998 ; McGraw et al.	24283
@NP	Taoka and Okajima , 1998	24283
@NP	Taoka and Okajima	24283
@NP	1998	24302
@NP	et al.	24315
@NP	2001	24323
@NP	15 and 30 min posttrauma	24338
@NP	15	24338
@NP	30 min posttrauma	24345
@NP	small hemorrhages	24364
@NP	extravasation of erythrocytes and plasma into the perivascular spaces	24387
@NP	extravasation	24387
@NP	erythrocytes and plasma	24404
@NP	the perivascular spaces	24433
@NP	2 to 7 days	24476
@NP	massive number of macrophages and other polymorphonucleate cells	24489
@NP	massive number	24489
@NP	macrophages and other polymorphonucleate cells	24507
@NP	macrophages	24507
@NP	other polymorphonucleate cells	24523
@NP	the lesion site	24561
@NP	Swollen axons with or without myelin	24578
@NP	Swollen axons	24578
@NP	myelin	24608
@NP	the first few days	24645
@NP	injury	24670
@NP	Several days	24678
@NP	the hemorrhagic zone	24698
@NP	cavitation and the adjacent areas	24725
@NP	cavitation	24725
@NP	the adjacent areas	24740
@NP	patchy necrosis , often with sharply defined margins	24767
@NP	patchy necrosis	24767
@NP	margins	24811
@NP	3 -- 5 days after injury	24827
@NP	3	24827
@NP	5 days after injury	24829
@NP	5 days	24829
@NP	injury	24842
@NP	reactive astrocytes	24850
@NP	wall	24879
@NP	the lesioned region	24888
@NP	Astrocytes	24909
@NP	this	24931
@NP	the expression of the structural protein GFAP	24950
@NP	the expression	24950
@NP	the structural protein GFAP	24968
@NP	the adjacent undamaged parenchyma toward the injured site	25012
@NP	the adjacent undamaged parenchyma	25012
@NP	the injured site	25053
@NP	their processes	25099
@NP	the reactive astrocytes around the lesioned area	25130
@NP	the reactive astrocytes	25130
@NP	the lesioned area	25161
@NP	leptomeningeal cells	25180
@NP	the surface of the CNS , as well as fibroblasts	25230
@NP	the surface of the CNS	25230
@NP	the surface	25230
@NP	the CNS	25245
@NP	fibroblasts	25265
@NP	the wound cavity and aid in the reformation of the basal lamina	25291
@NP	the wound cavity and aid	25291
@NP	the reformation of the basal lamina	25319
@NP	the reformation	25319
@NP	the basal lamina	25338
@NP	All these cells	25356
@NP	the named gliotic scar	25383
@NP	the necrotic cord parenchyma	25420
@NP	the rest of undamaged spinal cord	25454
@NP	the rest	25454
@NP	undamaged spinal cord	25466
@NP	The photochemical method of spinal cord damage	25489
@NP	The photochemical method	25489
@NP	spinal cord damage	25517
@NP	histopathological similarities	25540
@NP	contusion and compression experimental lesions	25576
@NP	previous studies	25627
@NP	we	25645
@NP	the first 60 min posttrauma	25669
@NP	light and electron microscopy	25698
@NP	an important cytotoxic edema	25735
@NP	astrocytic swelling	25769
@NP	hemorrhagic extravasation	25790
@NP	myelin degradation in the lesion site	25821
@NP	myelin degradation	25821
@NP	the lesion site	25843
@NP	15 days	25866
@NP	a cavity	25875
@NP	the necrotic area	25900
@NP	GFAP - and proteoglycan - stained astrocytes	25946
@NP	GFAP - and proteoglycan -	25946
@NP	GFAP	25946
@NP	proteoglycan	25956
@NP	astrocytes	25978
@NP	this cavity -LRB- Verdu ' et al. , 2001 , 2002 -RRB-	26010
@NP	this cavity	26010
@NP	Verdu ' et al.	26023
@NP	Verdu ' et	26023
@NP	Verdu '	26023
@NP	et	26030
@NP	al.	26033
@NP	2001 , 2002	26038
@NP	2001	26038
@NP	2002	26044
@NP	A photochemical lesion in adult rats	26051
@NP	A photochemical lesion	26051
@NP	adult rats	26077
@NP	severity of spinal cord injury	26106
@NP	severity	26106
@NP	spinal cord injury	26118
@NP	the illumination time	26152
@NP	functional , electrophysiological , and morphological consequences	26175
@NP	Animals	26271
@NP	1 min	26294
@NP	small spinal cavities	26307
@NP	the dorsal funiculi	26339
@NP	The cavity	26360
@NP	dorsal horns	26407
@NP	animals irradiated for 2.5 min	26423
@NP	animals	26423
@NP	2.5 min	26446
@NP	the dorsolateral funiculi also in animals irradiated 5 min	26455
@NP	dorsolateral funiculi	26459
@NP	animals	26489
@NP	the ventrolateral funiculi	26523
@NP	those irradiated for 10	26553
@NP	those irradiated	26553
@NP	10	26574
@NP	min -LRB- Verdu ' et al. , 2002 -RRB-	26577
@NP	min	26577
@NP	Verdu ' et al. , 2002	26582
@NP	Verdu '	26582
@NP	et al. , 2002	26589
@NP	et al.	26589
@NP	2002	26597
@NP	A significant negative relationship	26604
@NP	the area	26658
@NP	cavity of the spinal cord	26670
@NP	cavity	26670
@NP	the spinal cord	26680
@NP	the functional and electrophysiological impairment	26700
@NP	Garcı ' a-Alı ' as et al. , 2002	26752
@NP	Garcı '	26752
@NP	a-Alı ' as et al. , 2002	26758
@NP	a-Alı	26758
@NP	et al.	26767
@NP	2002	26775
@NP	This experimental model	26782
@NP	different therapeutic strategies	26857
@NP	neuroprotection and central regeneration	26901
@NP	neuroprotection	26901
@NP	central regeneration	26921
@NP	The ability of the OECs to promote axonal regeneration	26943
@NP	The ability	26943
@NP	the OECs	26958
@NP	axonal regeneration	26978
@NP	several regions of the central nervous system	27023
@NP	several regions	27023
@NP	the central nervous system	27042
@NP	Transplants	27070
@NP	OECs	27094
@NP	the reentry	27107
@NP	dorsal root axons	27135
@NP	the dorsal gray matter -LRB- Ramo ' n-Cueto and Nieto-Sampedro , 1994 -RRB-	27158
@NP	the dorsal gray matter	27158
@NP	Ramo ' n-Cueto and Nieto-Sampedro , 1994	27182
@NP	Ramo ' n-Cueto and Nieto-Sampedro	27182
@NP	Ramo '	27182
@NP	1994	27215
@NP	the synapses formed by these regenerating sensory fibers	27225
@NP	the synapses	27225
@NP	these regenerating sensory fibers	27248
@NP	functional restitution	27290
@NP	spinal reflex arcs -LRB- Navarro et al. , 1999 ; Taylor et al. , 2001 -RRB-	27316
@NP	spinal reflex arcs	27316
@NP	Navarro	27336
@NP	et al. , 1999 ; Taylor et al. , 2001	27344
@NP	et al.	27344
@NP	1999 ; Taylor et al.	27352
@NP	1999	27352
@NP	Taylor et al.	27358
@NP	Taylor	27358
@NP	et al.	27365
@NP	2001	27373
@NP	the corticospinal tract	27385
@NP	OECs transplanted into the lesion site	27431
@NP	OECs	27431
@NP	the lesion site	27454
@NP	the elongation of corticospinal axons	27479
@NP	the elongation	27479
@NP	corticospinal axons	27497
@NP	the transplanted area -LRB- Li et al. , 1998 -RRB-	27527
@NP	the transplanted area	27527
@NP	Li	27550
@NP	et al. , 1998	27553
@NP	et al.	27553
@NP	1998	27561
@NP	Functional recovery	27568
@NP	OECs-transplanted rats in comparison with vehicle-injected animals	27591
@NP	OECs-transplanted rats	27591
@NP	comparison with vehicle-injected animals	27617
@NP	comparison	27617
@NP	vehicle-injected animals	27633
@NP	complete transection of the adult rat spinal cord	27687
@NP	complete transection	27687
@NP	the adult rat spinal cord	27711
@NP	Ramo ' n-Cueto et al. -LRB- 2000 -RRB-	27738
@NP	Ramo ' n-Cueto et al.	27738
@NP	Ramo ' n-Cueto	27738
@NP	Ramo '	27738
@NP	et al.	27751
@NP	2000	27759
@NP	7 months after surgery , about 20 % of OECs-transplanted rats	27779
@NP	7 months	27779
@NP	surgery , about 20 % of OECs-transplanted rats	27794
@NP	surgery	27794
@NP	20 % of OECs-transplanted rats	27809
@NP	20 %	27809
@NP	OECs-transplanted rats	27816
@NP	a grid	27850
@NP	a slope of 90 °	27862
@NP	a slope	27862
@NP	90 °	27873
@NP	none of the DMEM-injected rats	27886
@NP	none	27886
@NP	the DMEM-injected rats	27894
@NP	this test	27924
@NP	addition	27938
@NP	OECs-transplanted rats	27948
@NP	positive responses	27978
@NP	light skin contact and propioceptive stimuli 7 months postsurgery	28000
@NP	light skin contact	28000
@NP	propioceptive stimuli 7 months postsurgery	28023
@NP	propioceptive stimuli 7 months	28023
@NP	propioceptive stimuli	28023
@NP	7 months	28045
@NP	postsurgery	28054
@NP	interest	28070
@NP	the functional recovery	28087
@NP	the OECs-transplanted group	28123
@NP	that in the DMEM group	28163
@NP	that	28163
@NP	the DMEM group	28171
@NP	3 months postoperation -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	28208
@NP	3 months	28208
@NP	postoperation -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	28217
@NP	postoperation	28217
@NP	Ramo ' n-Cueto et al. , 2000	28232
@NP	Ramo ' n-Cueto et al.	28232
@NP	Ramo ' n-Cueto	28232
@NP	Ramo '	28232
@NP	et al.	28245
@NP	2000	28253
@NP	Lu et al. -LRB- 2001 -RRB-	28260
@NP	Lu et al.	28260
@NP	Lu	28260
@NP	et al.	28263
@NP	2001	28271
@NP	complete spinal cord transection at T10	28303
@NP	complete spinal cord transection	28303
@NP	T10	28339
@NP	OECs-transplanted rats	28344
@NP	hindlimb usage	28376
@NP	the openfield walking test	28398
@NP	they	28426
@NP	8 -- 10 weeks postsurgery	28445
@NP	8	28445
@NP	10 weeks	28447
@NP	OECs-transplanted rats	28469
@NP	a BBB score	28500
@NP	6 -- 8 , whereas the BBB score of the nontransplanted rats averaged only 2	28521
@NP	6 -- 8	28521
@NP	the BBB score of the nontransplanted rats	28534
@NP	the BBB score	28534
@NP	the nontransplanted rats	28551
@NP	only 2	28585
@NP	Shen et al. -LRB- 2002 -RRB-	28603
@NP	Shen et al.	28603
@NP	Shen	28603
@NP	et al.	28608
@NP	2002	28616
@NP	10 weeks after spinal cord transection	28639
@NP	10 weeks	28639
@NP	spinal cord transection	28654
@NP	5 of 12 OECs-transplanted rats	28679
@NP	5	28679
@NP	12 OECs-transplanted rats	28684
@NP	recordable motor-evoked potentials	28717
@NP	none of the rats that received DMEM alone	28761
@NP	none	28761
@NP	the rats that received DMEM alone	28769
@NP	the rats	28769
@NP	DMEM	28792
@NP	MEPs	28807
@NP	All these findings	28813
@NP	OECs transplanted in severe spinal cord injuries	28849
@NP	OECs	28849
@NP	severe spinal cord injuries	28870
@NP	functional recovery	28906
@NP	Several factors	28927
@NP	the abilities of OECs	28955
@NP	the abilities	28955
@NP	OECs	28972
@NP	regeneration of central axons and functional recovery	28988
@NP	regeneration	28988
@NP	central axons and functional recovery	29004
@NP	central axons	29004
@NP	functional recovery	29022
@NP	spinal cord injuries	29048
@NP	OECs	29086
@NP	nerve	29099
@NP	growth factor	29105
@NP	NGF	29120
@NP	brain-derived neurotrophic factor -LRB- BDNF -RRB-	29126
@NP	brain-derived neurotrophic factor	29126
@NP	BDNF	29161
@NP	glia cell line-derived neurotrophic factor -LRB- GDNF -RRB-	29168
@NP	glia cell line-derived neurotrophic factor	29168
@NP	glia cell	29168
@NP	line-derived neurotrophic factor	29178
@NP	GDNF	29212
@NP	their receptors -LRB- Woodhall et al. , 2001 -RRB-	29223
@NP	their receptors	29223
@NP	Woodhall	29240
@NP	et al. , 2001	29249
@NP	et al.	29249
@NP	2001	29257
@NP	OECs	29264
@NP	neurotrophin 4/5	29282
@NP	Boruch	29300
@NP	et al. , 2001	29307
@NP	et al.	29307
@NP	2001	29315
@NP	p-75 low-affinity NGF receptor -LRB- Ramo ' n-Cueto et al. , 1993 -RRB-	29325
@NP	p-75	29325
@NP	low-affinity NGF receptor -LRB- Ramo ' n-Cueto et al. , 1993 -RRB-	29330
@NP	low-affinity NGF receptor	29330
@NP	Ramo ' n-Cueto et al. , 1993	29357
@NP	Ramo ' n-Cueto et al.	29357
@NP	Ramo ' n-Cueto	29357
@NP	Ramo '	29357
@NP	et al.	29370
@NP	1993	29378
@NP	It	29385
@NP	all these neurotrophic factors	29407
@NP	sprouting and regeneration of central axons	29446
@NP	sprouting and regeneration	29446
@NP	central axons	29476
@NP	sensory axons	29509
@NP	NGF , BDNF , and neurotrophin	29541
@NP	NGF	29541
@NP	BDNF	29546
@NP	neurotrophin	29556
@NP	3 -LRB- NT-3 -RRB- -LRB- Bradbury et al. , 1999 ; Oudega and Hagg , 1999 -RRB-	29569
@NP	3 -LRB- NT-3 -RRB-	29569
@NP	Bradbury	29579
@NP	et al. , 1999 ; Oudega and Hagg , 1999	29588
@NP	et al.	29588
@NP	1999 ; Oudega and Hagg	29596
@NP	1999	29596
@NP	Oudega and Hagg	29602
@NP	1999	29619
@NP	Lesioned rubrospinal and corticospinal axons	29626
@NP	Lesioned rubrospinal	29626
@NP	corticospinal axons	29651
@NP	BDNF	29694
@NP	regeneration	29715
@NP	rubrospinal axons -LRB- Liu et al. , 1999 ; Plunet et al. , 2002 -RRB-	29731
@NP	rubrospinal axons	29731
@NP	Liu	29750
@NP	et al. , 1999 ; Plunet et al. , 2002	29754
@NP	et al.	29754
@NP	1999 ; Plunet et al.	29762
@NP	1999	29762
@NP	Plunet et al.	29768
@NP	Plunet	29768
@NP	et al.	29775
@NP	2002	29783
@NP	survival	29793
@NP	regrowth of lesioned corticospinal axons -LRB- Lu et al. , 2001 -RRB-	29810
@NP	regrowth	29810
@NP	lesioned corticospinal axons -LRB- Lu et al. , 2001 -RRB-	29822
@NP	lesioned corticospinal axons	29822
@NP	Lu	29852
@NP	et al. , 2001	29855
@NP	et al.	29855
@NP	2001	29863
@NP	NT-4	29870
@NP	5	29875
@NP	atrophy of rat rubrospinal neurons	29886
@NP	atrophy	29886
@NP	rat rubrospinal neurons	29897
@NP	axotomy	29927
@NP	rubrospinal regeneration -LRB- Kobayashi et al. , 1997 -RRB-	29948
@NP	rubrospinal regeneration	29948
@NP	Kobayashi	29974
@NP	et al. , 1997	29984
@NP	et al.	29984
@NP	1997	29992
@NP	GDNF	29999
@NP	survival and axonal regeneration	30013
@NP	noradrenergic neurons	30049
@NP	the locus coeruleus -LRB- Arenas et al. , 1995 ; Holm et al 2002 -RRB-	30074
@NP	the locus coeruleus	30074
@NP	Arenas	30095
@NP	et al. , 1995 ; Holm et al 2002	30102
@NP	et al. , 1995 ; Holm et al	30102
@NP	et al. , 1995	30102
@NP	et al.	30102
@NP	1995	30110
@NP	Holm et al	30116
@NP	Holm	30116
@NP	et al	30121
@NP	2002	30127
@NP	addition	30137
@NP	OECs	30147
@NP	molecules	30160
@NP	neurite extension	30194
@NP	L1 , laminin , N-CAM , PSA-NCAM , and fibronectin	30220
@NP	Ramo ' n-Cueto and Avila , 1998	30267
@NP	Ramo ' n-Cueto	30267
@NP	Ramo '	30267
@NP	n-Cueto	30272
@NP	Avila , 1998	30284
@NP	Avila	30284
@NP	1998	30291
@NP	These findings	30298
@NP	OECs	30326
@NP	the survival and regeneration of the main	30356
@NP	the survival and regeneration	30356
@NP	the main	30389
@NP	pathways in the adult spinal cord	30423
@NP	pathways	30423
@NP	the adult spinal cord	30435
@NP	it	30467
@NP	OECs transplanted into the lesioned cord	30484
@NP	OECs	30484
@NP	the lesioned cord	30507
@NP	all these neurotrophic factors	30550
@NP	OECs transplanted in lesioned spinal cords	30592
@NP	OECs	30592
@NP	lesioned spinal cords	30613
@NP	a downregulation of GFAP and proteoglycan expression	30642
@NP	a downregulation	30642
@NP	GFAP and proteoglycan expression	30662
@NP	the reactive astrocytes -LRB- Verdu ' et al. , 2001 -RRB-	30698
@NP	reactive astrocytes -LRB- Verdu ' et al. , 2001 -RRB-	30702
@NP	reactive astrocytes	30702
@NP	Verdu ' et al. , 2001	30723
@NP	Verdu '	30723
@NP	et al. , 2001	30730
@NP	et al.	30730
@NP	2001	30738
@NP	the present study	30748
@NP	we	30767
@NP	these results	30778
@NP	a longer time	30795
@NP	3 months postlesion	30810
@NP	3 months	30810
@NP	postlesion	30819
@NP	the injury process	30836
@NP	a steady state	30867
@NP	Studies that have used cocultures with astrocytes	30883
@NP	Studies	30883
@NP	cocultures	30906
@NP	astrocytes	30922
@NP	OECs	30945
@NP	overexpression of chondroitin sulfate proteoglycans -LRB- CSPGs -RRB-	30965
@NP	overexpression	30965
@NP	chondroitin sulfate proteoglycans -LRB- CSPGs -RRB-	30983
@NP	chondroitin sulfate proteoglycans	30983
@NP	CSPGs	31018
@NP	astrocytes	31028
@NP	Schwann cells	31059
@NP	CSPG expression	31083
@NP	astrocytes -LRB- Lakatos et al. , 2000 , 2002 -RRB-	31102
@NP	astrocytes	31102
@NP	Lakatos	31114
@NP	et al. , 2000 , 2002	31122
@NP	et al.	31122
@NP	2000	31130
@NP	2002	31136
@NP	In vitro studies	31143
@NP	proteoglycan	31178
@NP	neurite outgrowth	31200
@NP	a monoclonal antibody against proteoglycan	31228
@NP	a monoclonal antibody	31228
@NP	proteoglycan	31258
@NP	this inhibitory activity -LRB- Bovolenta et al. , 1997 -RRB-	31283
@NP	this inhibitory activity	31283
@NP	Bovolenta	31309
@NP	et al. , 1997	31319
@NP	et al.	31319
@NP	1997	31327
@NP	Plant et al. -LRB- 2001 -RRB-	31344
@NP	Plant et al.	31344
@NP	Plant	31344
@NP	et al.	31350
@NP	2001	31358
@NP	CSPG immunoreactivity	31378
@NP	the graft-host cord interface	31417
@NP	it	31452
@NP	astrocytes and fibroblasts	31475
@NP	These findings	31503
@NP	accumulation of proteoglycan compounds near the wound	31531
@NP	accumulation	31531
@NP	proteoglycan compounds near the wound	31547
@NP	proteoglycan compounds	31547
@NP	the wound	31575
@NP	the elongation of injured central axons	31596
@NP	the elongation	31596
@NP	injured central axons	31614
@NP	fact	31640
@NP	chondroitinase-ABC treatment , which degrades CSPGs ,	31646
@NP	chondroitinase-ABC treatment	31646
@NP	CSPGs	31691
@NP	neurite elongation -LRB- Zuo et al. , 1998 -RRB-	31705
@NP	neurite elongation	31705
@NP	Zuo	31725
@NP	et al. , 1998	31729
@NP	et al.	31729
@NP	1998	31737
@NP	axonal regeneration	31756
@NP	spinal cord injury -LRB- Yick et al. , 2000 ; Bradbury et al. , 2002 -RRB-	31782
@NP	spinal cord injury	31782
@NP	Yick	31802
@NP	et al. , 2000 ; Bradbury et al. , 2002	31807
@NP	et al.	31807
@NP	2000 ; Bradbury et al.	31815
@NP	2000	31815
@NP	Bradbury et al.	31821
@NP	Bradbury	31821
@NP	et al.	31830
@NP	2002	31838
@NP	Our results -LRB- Verdu ' et al. , 2001 -RRB-	31845
@NP	results -LRB- Verdu ' et al. , 2001 -RRB-	31849
@NP	results	31849
@NP	Verdu ' et al. , 2001	31858
@NP	Verdu '	31858
@NP	et al. , 2001	31865
@NP	et al.	31865
@NP	2001	31873
@NP	OECs	31892
@NP	reactive astrocytes	31929
@NP	their reactivity	31959
@NP	a protective environment	31989
@NP	We	32015
@NP	OECs	32038
@NP	other cells	32064
@NP	microglia and leukocytes	32085
@NP	the cord parenchyma	32128
@NP	the first hours after injury	32155
@NP	the first hours	32155
@NP	injury	32177
@NP	their proinflammatory response	32196
@NP	The preservation	32228
@NP	more cord parenchyma	32248
@NP	transplanted OECs	32272
@NP	the photochemical spinal cord injury -LRB- Verdu ' et al. , 2001 -RRB-	32296
@NP	the photochemical spinal cord injury	32296
@NP	Verdu ' et al. , 2001	32334
@NP	Verdu '	32334
@NP	et al. , 2001	32341
@NP	et al.	32341
@NP	2001	32349
@NP	the present work	32369
@NP	the proregenerative and promodulating inflammatory properties of OECs	32412
@NP	the proregenerative and promodulating inflammatory properties	32412
@NP	OECs	32477
@NP	the effects of OECs	32492
@NP	the effects	32492
@NP	OECs	32507
@NP	their ability to migrate inside the spinal cord parenchyma	32536
@NP	the spinal cord parenchyma	32568
@NP	a previous study	32599
@NP	we	32617
@NP	prelabeled OECs	32636
@NP	T12-L1 spinal cord levels	32669
@NP	OECs	32696
@NP	rostral -LRB- T9 -- T10 -RRB- and caudal -LRB- L4 -- L6 -RRB- spinal cord levels	32722
@NP	rostral -LRB- T9 -- T10 -RRB-	32722
@NP	rostral	32722
@NP	T9 -- T10	32731
@NP	T9	32731
@NP	T10	32734
@NP	caudal -LRB- L4 -- L6 -RRB- spinal cord levels	32743
@NP	caudal	32743
@NP	L4 -- L6	32751
@NP	L4	32751
@NP	L6	32754
@NP	spinal cord levels	32758
@NP	15 days	32777
@NP	spinal cord injury and transplantation -LRB- Verdu ' et al. , 2001 -RRB-	32791
@NP	spinal cord injury	32791
@NP	transplantation -LRB- Verdu ' et al. , 2001 -RRB-	32814
@NP	transplantation	32814
@NP	Verdu ' et al. , 2001	32831
@NP	Verdu '	32831
@NP	et al. , 2001	32838
@NP	et al.	32838
@NP	2001	32846
@NP	Boruch et al. -LRB- 2001 -RRB-	32853
@NP	Boruch et al.	32853
@NP	Boruch	32853
@NP	et al.	32860
@NP	2001	32868
@NP	1 month after dorsal hemisection , p75-positive OECs	32893
@NP	1 month	32893
@NP	dorsal hemisection , p75-positive OECs	32907
@NP	dorsal hemisection	32907
@NP	p75-positive OECs	32927
@NP	the injured dorsal aspect	32973
@NP	the uninjured ventral portion of the spinal cord	33017
@NP	the uninjured ventral portion	33017
@NP	the spinal cord	33050
@NP	addition	33070
@NP	OECs migration	33080
@NP	transplantation	33114
@NP	the hippocampus -LRB- Gudin˜ o-Cabrera and Nieto-Sampedro , 1996 -RRB-	33133
@NP	the hippocampus	33133
@NP	Gudin˜ o-Cabrera and Nieto-Sampedro , 1996	33150
@NP	Gudin˜ o-Cabrera and Nieto-Sampedro	33150
@NP	1996	33187
@NP	the transected medial longitudinal fascicle	33203
@NP	Gudin˜ o-Cabrera	33248
@NP	et al. , 2000	33265
@NP	et al.	33265
@NP	2000	33273
@NP	the other hand	33283
@NP	previous studies	33299
@NP	transplanted OECs	33335
@NP	2 -LRB- Gudin˜ o-Cabrera et al. , 2000 -RRB-	33366
@NP	2	33366
@NP	Gudin˜ o-Cabrera	33369
@NP	et al. , 2000	33386
@NP	et al.	33386
@NP	2000	33394
@NP	7 months -LRB- Ramo ' n-Cueto et al. , 2000 -RRB-	33403
@NP	7 months	33403
@NP	Ramo ' n-Cueto et al. , 2000	33413
@NP	Ramo ' n-Cueto et al.	33413
@NP	Ramo ' n-Cueto	33413
@NP	Ramo '	33413
@NP	et al.	33426
@NP	2000	33434
@NP	transplantation	33446
@NP	All these findings	33463
@NP	OECs	33504
@NP	large distances	33541
@NP	the central nervous system	33578
@NP	conclusion	33609
@NP	OEC transplantation	33621
@NP	a promising therapeutic procedure	33653
@NP	injured spinal cords	33701
@NP	The results reported in the present study	33723
@NP	The results	33723
@NP	the present study	33747
@NP	the first evidence	33773
@NP	transplants of OECs	33797
@NP	transplants	33797
@NP	OECs	33812
@NP	loss of cord parenchyma	33825
@NP	loss	33825
@NP	cord parenchyma	33833
@NP	functional recovery	33861
@NP	incomplete spinal cord injury , the main type of human spinal cord injury	33887
@NP	incomplete spinal cord injury	33887
@NP	the main type of human spinal cord injury	33918
@NP	the main type	33918
@NP	human spinal cord injury	33935
@NP	the clinical use of this therapeutic procedure	33970
@NP	the clinical use	33970
@NP	this therapeutic procedure	33990
@NP	further studies in animal models	34026
@NP	further studies	34026
@NP	animal models	34045
@VP	Transplanted in Lesioned Spinal Cord	29
@VP	Prevent Loss of Spinal Cord Parenchyma	66
@VP	studied the effects of olfactory ensheathing cells	259
@VP	transplanted in a photochemical spinal cord injury in adult rats	317
@VP	bathed with rose Bengal for 10 min	450
@VP	rose Bengal for 10 min	462
@VP	illuminated with visible light	489
@VP	connected to a halogen lamp for 2.5 min at maximal intensity of 8 kLux	547
@VP	received a suspension of OECs in DMEM	638
@VP	received DMEM alone	700
@VP	evoked potentials by electrophysiological techniques	844
@VP	were evaluated for 3 months postsurgery	897
@VP	evaluated for 3 months postsurgery	902
@VP	were perfused with paraformaldehyde	956
@VP	perfused with paraformaldehyde	961
@VP	were immunostained against GFAP	1064
@VP	immunostained against GFAP	1069
@VP	was measured from the GFAPimmunolabeled cord sections	1142
@VP	measured from the GFAPimmunolabeled cord sections	1146
@VP	evoked potentials	1258
@VP	was lower in OEC - than in DMEM-injected rats	1422
@VP	was significantly larger in OECs-transplanted rats than in DMEM-injected animals	1502
@VP	injured axons	1771
@VP	fail to regenerate across the lesion site	1785
@VP	to regenerate across the lesion site	1790
@VP	regenerate across the lesion site	1793
@VP	do not reestablish synaptic connections with their targets	1831
@VP	reestablish synaptic connections with their targets	1838
@VP	to understand the factors that limit spinal cord regeneration	2098
@VP	understand the factors that limit spinal cord regeneration	2101
@VP	limit spinal cord regeneration	2129
@VP	promote neural protection and axonal regeneration	2726
@VP	have been used for repairing spinal cord lesions	3045
@VP	been used for repairing spinal cord lesions	3050
@VP	used for repairing spinal cord lesions	3055
@VP	repairing spinal cord lesions	3064
@VP	restore central nerve conduction -LRB- Imaizumi et al. , 1998 , 2000 -RRB-	3223
@VP	permits the regeneration of central axons	4380
@VP	evaluated using open-field walking	4645
@VP	using open-field walking	4655
@VP	were used as functional tests	4724
@VP	used as functional tests	4729
@VP	were used for evaluating the integrity of spinal cord pathways	4798
@VP	used for evaluating the integrity of spinal cord pathways	4803
@VP	evaluating the integrity of spinal cord pathways	4812
@VP	was measured from spinal cord sections immunostained against GFAP	4900
@VP	measured from spinal cord sections immunostained against GFAP	4904
@VP	immunostained against GFAP	4939
@VP	was stripped off with fine forceps	5428
@VP	stripped off with fine forceps	5432
@VP	was done by gentle trituration using a flame-constricted Pasteur pipette	5653
@VP	done by gentle trituration using a flame-constricted Pasteur pipette	5657
@VP	using a flame-constricted Pasteur pipette	5684
@VP	recovered by centrifugation at 900 rpm for 7 min	5946
@VP	resuspended in culture medium	5999
@VP	coated with poly-L-lysine -LRB- 10 µg/ml ; Sigma -RRB-	6072
@VP	incubated in 5 % CO2 at 37 °C	6121
@VP	was DMEM with 10 % FCS	6165
@VP	expanding OECs -LRB- Gudin˜ o-Cabrera and Nieto-Sampedro , 2000 -RRB-	6257
@VP	reaching confluency -LRB- about 15 days in culture -RRB-	6323
@VP	rinsed twice with HBSS without calcium and magnesium , at 4 °C	6394
@VP	was arrested by the addition of medium	6544
@VP	arrested by the addition of medium	6548
@VP	was recovered by centrifugation at 900 rpm for 7 min	6604
@VP	recovered by centrifugation at 900 rpm for 7 min	6608
@VP	precoated with goat antimouse IgG	6743
@VP	attached with mouse monoclonal 192 IgG antibodies	6781
@VP	recognize the p75-NGF receptor -LRB- Chemicon -RRB-	6836
@VP	resuspended in DMEM medium	6900
@VP	incubated with DBM-coated magnetic beads , for 40 min , with mixing	6931
@VP	mixing	6990
@VP	selectively attached to the magnetic beads	7008
@VP	did not express p75-NGF receptor with the help of a potent magnet	7086
@VP	express p75-NGF receptor with the help of a potent magnet	7094
@VP	were washed with DMEM for removing the unattached p75 negative cells	7265
@VP	washed with DMEM for removing the unattached p75 negative cells	7270
@VP	removing the unattached p75 negative cells	7291
@VP	resuspended in freezing medium -LRB- Sigma -RRB-	7364
@VP	transferred to a -20 °C freezer for 10 min , then to a deep freezer at -80 °C	7422
@VP	washed two times by centrifugation -LRB- 900 rpm , 7 min -RRB- in DMEM	7558
@VP	was resuspended in the same medium	7634
@VP	resuspended in the same medium	7638
@VP	were transplanted within 2 h of thawing	7680
@VP	transplanted within 2 h of thawing	7685
@VP	had flatten appearance	7873
@VP	flatten appearance	7877
@VP	were also identified in our cultures	7932
@VP	identified in our cultures	7942
@VP	were p75-positive	8094
@VP	anesthetized with sodium pentobarbital -LRB- 50 mg/kg , i.p. -RRB-	8431
@VP	placed prone on a heating pad to maintain body temperature constant	8491
@VP	to maintain body temperature constant	8521
@VP	maintain body temperature constant	8524
@VP	was shaved and disinfected with povidone iodine	8584
@VP	shaved and disinfected with povidone iodine	8588
@VP	extending from mid to low thoracic vertebrae	8685
@VP	was done	8730
@VP	done	8734
@VP	was exposed by a dorsal laminectomy at T8 vertebra	8756
@VP	exposed by a dorsal laminectomy at T8 vertebra	8760
@VP	was carefully cut to facilitate penetration of solutions	8817
@VP	cut to facilitate penetration of solutions	8831
@VP	to facilitate penetration of solutions	8835
@VP	facilitate penetration of solutions	8838
@VP	was applied directly on the exposed spinal cord for 10 min	8915
@VP	applied directly on the exposed spinal cord for 10 min	8919
@VP	dye	8986
@VP	was removed by a double saline rinse	8990
@VP	removed by a double saline rinse	8994
@VP	positioned 10 mm on top of the cord	9141
@VP	was connected to a halogen lamp -LRB- Raypa , Barcelona , Spain -RRB-	9194
@VP	connected to a halogen lamp -LRB- Raypa , Barcelona , Spain -RRB-	9198
@VP	was illuminated at maximal intensity of 8 kLux for 2.5 min	9269
@VP	illuminated at maximal intensity of 8 kLux for 2.5 min	9273
@VP	received a total of 180,000 OECs in DMEM	9689
@VP	was closed	10014
@VP	closed	10018
@VP	were kept in a warm environment until full recovery	10041
@VP	kept in a warm environment until full recovery	10046
@VP	to prevent neuropathic pain -LRB- Navarro et al. , 1994 -RRB-	10159
@VP	prevent neuropathic pain -LRB- Navarro et al. , 1994 -RRB-	10162
@VP	adhered to the recommendations of the European Union and the U.S.	10239
@VP	Department of Health for the care and use of laboratory animals	10305
@VP	were approved by the ethics committee of our institution	10373
@VP	approved by the ethics committee of our institution	10378
@VP	using the open-field walking scoring system	10589
@VP	measuring the locomotor ability for 5 min	10637
@VP	observed the hindlimb movements of the rat	10823
@VP	was the mean value of both examiners	10980
@VP	could maintain a stable position for 5 s on the inclined plane	11244
@VP	maintain a stable position for 5 s on the inclined plane	11250
@VP	was recorded	11307
@VP	recorded	11311
@VP	using a plantar algesimeter -LRB- Hargreaves et al. , 1988 -RRB-	11386
@VP	was placed into a plastic box with an elevated glass floor	11458
@VP	placed into a plastic box with an elevated glass floor	11462
@VP	was focused directly onto the plantar surface of the hindpaw	11585
@VP	focused directly onto the plantar surface of the hindpaw	11589
@VP	coupled with infrared detectors directed to the plantar surface	11743
@VP	directed to the plantar surface	11775
@VP	was limited to 40 s to avoid skin damage	11840
@VP	limited to 40 s to avoid skin damage	11844
@VP	to avoid skin damage	11860
@VP	avoid skin damage	11863
@VP	was the mean of three trials separated by 5-min resting periods	11903
@VP	separated by 5-min resting periods	11932
@VP	tested to evaluate the integrity of spinal cord descending and ascending tracts	12045
@VP	to evaluate the integrity of spinal cord descending and ascending tracts	12052
@VP	evaluate the integrity of spinal cord descending and ascending tracts	12055
@VP	descending and ascending tracts	12093
@VP	circulating pump to maintain skin temperature above 32 °C	12276
@VP	to maintain skin temperature above 32 °C	12293
@VP	maintain skin temperature above 32 °C	12296
@VP	using monopolar needle electrodes placed at the tibialis anterior muscle	12379
@VP	placed at the tibialis anterior muscle	12413
@VP	stimulated by single rectangular pulses of 0.1-ms duration	12501
@VP	overlying the sensorimotor cortex	12649
@VP	the anode at the nose	12687
@VP	inserted at the ankle	13031
@VP	Evoked responses were recorded using two needle electrodes	13054
@VP	were recorded using two needle electrodes	13071
@VP	recorded using two needle electrodes	13076
@VP	using two needle electrodes	13085
@VP	were recorded during 100 ms following each stimulus and averaged	13219
@VP	were recorded during 100 ms following each stimulus	13219
@VP	recorded during 100 ms following each stimulus	13224
@VP	averaged	13275
@VP	amplified	13302
@VP	filtered -LRB- bandpass 1 Hz/5 kHz for MEPs and 10 Hz/1 kHz for SSEPs -RRB-	13313
@VP	to measure the amplitude	13438
@VP	measure the amplitude	13441
@VP	evoked potentials -LRB- Nuwer , 1998 -RRB-	13486
@VP	To ensure reproducibility	13519
@VP	ensure reproducibility	13522
@VP	to secure the same placement on all animals guided by anatomical landmarks	13615
@VP	secure the same placement on all animals guided by anatomical landmarks	13618
@VP	guided by anatomical landmarks	13659
@VP	were performed before operation and at 14 , 30 , 60 , and 90 days postoperation	13722
@VP	performed before operation and at 14 , 30 , 60 , and 90 days postoperation	13727
@VP	removed , fixed in the same solution for 24 h , and divided in several segments	14049
@VP	removed	14049
@VP	fixed in the same solution for 24 h	14058
@VP	divided in several segments	14099
@VP	were cryoprotected in PBS containing 30 % sucrose and stored at 4 °C	14153
@VP	were cryoprotected in PBS containing 30 % sucrose	14153
@VP	cryoprotected in PBS containing 30 % sucrose	14158
@VP	containing 30 % sucrose	14179
@VP	stored at 4 °C	14206
@VP	mounted on gelatin-coated slides , dehydrated in ethanol , and mounted with DPX	14735
@VP	mounted on gelatin-coated slides	14735
@VP	dehydrated in ethanol	14769
@VP	mounted with DPX	14796
@VP	were incubated without primary antibody and processed as described above	14866
@VP	incubated without primary antibody and processed as described above	14871
@VP	incubated without primary antibody	14871
@VP	processed as described above	14910
@VP	described above	14923
@VP	equipped with epifluorescence using appropriate filters	14994
@VP	using appropriate filters	15024
@VP	attached to the microscope and analyzed using NIH Image software	15170
@VP	attached to the microscope	15170
@VP	analyzed using NIH Image software	15201
@VP	using NIH Image software	15210
@VP	stained against GFAP	15257
@VP	measuring the area of preserved cord parenchyma	15292
@VP	surrounding and delimiting the destroyed parenchyma	15409
@VP	surrounding	15409
@VP	delimiting the destroyed parenchyma	15425
@VP	made these measurements over the same images	15487
@VP	analyzed	15609
@VP	was the mean value of both subjects	15618
@VP	were studied	15715
@VP	studied	15720
@VP	were performed in a blinded manner	15818
@VP	performed in a blinded manner	15823
@VP	was used	15893
@VP	used	15897
@VP	are shown as mean ± SEM	15908
@VP	shown as mean ± SEM	15912
@VP	To examine specific differences between preand postoperative times	16069
@VP	examine specific differences between preand postoperative times	16072
@VP	was used	16153
@VP	used	16157
@VP	were considered significant if P < 0.05	16175
@VP	considered significant if P < 0.05	16180
@VP	Fig. 1	16225
@VP	opened circle	16455
@VP	filled circle	16480
@VP	rats of groups DMEM -LRB- left -RRB- and OECs -LRB- right -RRB- at 0 , 30 ,	16629
@VP	opened bar	17101
@VP	filled bar	17123
@VP	opened bar	17386
@VP	filled bar	17408
@VP	transplanted with OECs	17873
@VP	injected with DMEM	17937
@VP	showed a decrease of their body weight	17962
@VP	began to gain weight	18076
@VP	to gain weight	18082
@VP	gain weight	18085
@VP	showed normal locomotor behavior -LRB- scored 21 -RRB-	18161
@VP	scored 21	18195
@VP	decreased with respect to preoperative values	18274
@VP	were slightly higher in OEC rats with respect to DMEM animals	18633
@VP	were seen between the two groups from 14 to 90 days postoperation	18723
@VP	seen between the two groups from 14 to 90 days postoperation	18728
@VP	were about 47 °	18862
@VP	decreased to 36 °	18926
@VP	evaluated by plantar algesimetry	19256
@VP	had a latency of about 15 s in both experimental groups before lesion	19289
@VP	was similar to preoperative values in OEC rats	19498
@VP	increased to values about 24 and 19 s in groups DMEM and OEC	19594
@VP	tested	19745
@VP	recorded prior to operation	19801
@VP	showed a single wave with a mean latency of about 6 ms	19829
@VP	mean amplitude of about 15 mV in both groups -LRB- Fig. 2A -RRB-	19888
@VP	decreased markedly in group DMEM	20066
@VP	showing a mean amplitude of about 1 mV	20173
@VP	in all OEC rats with a mean value amplitude of about 12 mV	20217
@VP	showed MEP responses with a mean amplitude of about 15 mV	20448
@VP	studied -LRB- Fig. 3 -RRB-	20600
@VP	were observed	21161
@VP	observed	21166
@VP	remained intact	21472
@VP	Destroyed spinal cord parenchyma remains	21489
@VP	remains	21522
@VP	were seen in dorsal areas -LRB- Fig. 5A -RRB-	21530
@VP	seen in dorsal areas -LRB- Fig. 5A -RRB-	21535
@VP	heavily stained for GFAP	21921
@VP	were seen around the cavity or the desestructured cord parenchyma	21947
@VP	seen around the cavity or the desestructured cord parenchyma	21952
@VP	extending in all directions and heavily stained for GFAP -LRB- Fig. 5C -RRB-	22146
@VP	extending in all directions	22146
@VP	heavily stained for GFAP -LRB- Fig. 5C -RRB-	22178
@VP	showed a hypertrophied appearance	22256
@VP	showed slightly GFAP-stained cell bodies with thin processes -LRB- Fig. 5D -RRB-	22300
@VP	significantly prevented the loss of cord parenchyma	22514
@VP	improved the functional outcome during 3 months postinjury	22570
@VP	received an injection of medium	22659
@VP	showed better locomotor function and closer to normal nociceptive responses	22715
@VP	showed better locomotor function	22715
@VP	closer to normal nociceptive responses	22752
@VP	descending and ascending spinal pathways	23010
@VP	caudal to the level of injury -LRB- Kakulas , 1984 ; Geisler et al. , 1991 -RRB-	23478
@VP	producing graded spinal cord lesions	23616
@VP	graded spinal cord lesions	23626
@VP	studying regeneration in partially lesioned spinal cords	23657
@VP	partially lesioned spinal cords	23682
@VP	developed to simulate the compression type of acute cord trauma	23735
@VP	to simulate the compression type of acute cord trauma	23745
@VP	simulate the compression type of acute cord trauma	23748
@VP	include	23799
@VP	followed by cystic formation	24192
@VP	McGraw et al.	24308
@VP	were seen	24457
@VP	seen	24462
@VP	invade the lesion site	24554
@VP	are typically observed during the first few days after injury	24615
@VP	observed during the first few days after injury	24629
@VP	exhibit patchy necrosis , often with sharply defined margins	24759
@VP	often with sharply defined margins	24784
@VP	begin to wall off the lesioned region	24870
@VP	increasing the expression of the structural protein GFAP	24939
@VP	migrating from the adjacent undamaged parenchyma toward the injured site	24997
@VP	finally interdigitating their processes	25075
@VP	are normally found on the surface of the CNS , as well as fibroblasts	25208
@VP	found on the surface of the CNS , as well as fibroblasts	25221
@VP	migrate into the wound cavity and aid in the reformation of the basal lamina	25278
@VP	isolates the necrotic cord parenchyma from the rest of undamaged spinal cord	25411
@VP	was observed in the necrotic area , and hypertrophied	25884
@VP	was observed in the necrotic area	25884
@VP	observed in the necrotic area	25888
@VP	hypertrophied	25923
@VP	stained astrocytes	25970
@VP	were seen delimiting this cavity -LRB- Verdu ' et al. , 2001 , 2002 -RRB-	25989
@VP	seen delimiting this cavity -LRB- Verdu ' et al. , 2001 , 2002 -RRB-	25994
@VP	delimiting this cavity -LRB- Verdu ' et al. , 2001 , 2002 -RRB-	25999
@VP	can induce graded severity of spinal cord injury	26088
@VP	induce graded severity of spinal cord injury	26092
@VP	graded severity of spinal cord injury	26099
@VP	increasing the illumination time	26141
@VP	are progressively more severe	26240
@VP	irradiated for 1 min showed small spinal cavities involving the dorsal funiculi	26279
@VP	showed small spinal cavities involving the dorsal funiculi	26300
@VP	involving the dorsal funiculi	26329
@VP	irradiated for 2.5 min	26431
@VP	to promote neuroprotection and central regeneration	26890
@VP	promote neuroprotection and central regeneration	26893
@VP	to promote axonal regeneration	26967
@VP	promote axonal regeneration	26970
@VP	has been demonstrated in several regions of the central nervous system	26998
@VP	been demonstrated in several regions of the central nervous system	27002
@VP	demonstrated in several regions of the central nervous system	27007
@VP	formed by these regenerating sensory fibers	27238
@VP	was focally lesioned	27409
@VP	focally lesioned	27413
@VP	transplanted into the lesion site	27436
@VP	has also been reported after complete transection of the adult rat spinal cord	27658
@VP	been reported after complete transection of the adult rat spinal cord	27667
@VP	reported after complete transection of the adult rat spinal cord	27672
@VP	passed this test	27917
@VP	is	28079
@VP	observed in the OECs-transplanted group compared to that in the DMEM group	28111
@VP	improved hindlimb usage	28367
@VP	Using the openfield walking test	28392
@VP	averaged only 2	28576
@VP	received DMEM alone	28783
@VP	had MEPs	28803
@VP	transplanted in severe spinal cord injuries	28854
@VP	promote functional recovery	28898
@VP	in vitro OECs express nerve	29077
@VP	promote sprouting and regeneration of central axons	29438
@VP	Injured ascending sensory axons	29491
@VP	ascending sensory axons	29499
@VP	are responsive to NGF , BDNF , and neurotrophin	29523
@VP	prevents atrophy of rat rubrospinal neurons after axotomy	29877
@VP	promotes rubrospinal regeneration -LRB- Kobayashi et al. , 1997 -RRB-	29939
@VP	ascending and descending pathways in the adult spinal cord	30398
@VP	transplanted into the lesioned cord	30489
@VP	express and secrete all these neurotrophic factors	30530
@VP	transplanted in lesioned spinal cords	30597
@VP	has reached a steady state	30855
@VP	reached a steady state	30859
@VP	have used cocultures with astrocytes	30896
@VP	used cocultures with astrocytes	30901
@VP	cocultured Schwann cells	31048
@VP	increased CSPG expression in astrocytes -LRB- Lakatos et al. , 2000 , 2002 -RRB-	31073
@VP	inhibits neurite outgrowth	31191
@VP	neutralized this inhibitory activity -LRB- Bovolenta et al. , 1997 -RRB-	31271
@VP	was increased at the graft-host cord interface	31400
@VP	increased at the graft-host cord interface	31404
@VP	was associated with astrocytes and fibroblasts	31455
@VP	associated with astrocytes and fibroblasts	31459
@VP	may impair the elongation of injured central axons	31585
@VP	impair the elongation of injured central axons	31589
@VP	degrades CSPGs	31682
@VP	allows neurite elongation -LRB- Zuo et al. , 1998 -RRB-	31698
@VP	reducing their reactivity and creating a protective environment	31950
@VP	reducing their reactivity	31950
@VP	creating a protective environment	31980
@VP	modulating their proinflammatory response	32185
@VP	confirmed in the present work	32356
@VP	be potentiated by their ability to migrate inside the spinal cord parenchyma	32518
@VP	potentiated by their ability to migrate inside the spinal cord parenchyma	32521
@VP	to migrate inside the spinal cord parenchyma	32550
@VP	migrate inside the spinal cord parenchyma	32553
@VP	were injected at T12-L1 spinal cord levels	32652
@VP	injected at T12-L1 spinal cord levels	32657
@VP	were able to migrate within the injured dorsal aspect	32945
@VP	to migrate within the injured dorsal aspect	32955
@VP	migrate within the injured dorsal aspect	32958
@VP	did not enter the uninjured ventral portion of the spinal cord	33003
@VP	enter the uninjured ventral portion of the spinal cord	33011
@VP	transplanted in the central nervous system	33562
@VP	constitutes a promising therapeutic procedure for repairing injured spinal cords	33641
@VP	repairing injured spinal cords	33691
@VP	reported in the present study	33735
@VP	prevent loss of cord parenchyma	33817
@VP	requires further studies in animal models	34017
